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Abstract
Macular pigment (MP) is the shared term for three xanthophyllic- carotenoids:
lutein, zeaxanthin, and meso-zeaxanthin, which, relative to human serum
concentrations, are highly concentrated in the central macula. The term macular
pigment optical density (MPOD) refers to a quantifiable (typically in log units)
value of the peak optical absorption density of MP in the central retina. MP alters
the spectral composition of incident light due to its anatomic position relative to
the photoreceptors. In addition to its short wavelength filtering properties, MP
also exhibits potent antioxidant properties that have become the subject of
interest for a wide range of retinal conditions, most notably, age-related macular
degeneration.

Recently, a number of studies have focused their efforts on the spectral
properties of MP and its relationship with visual performance. These studies
have demonstrated a correlation between central MPOD and visual performance
measures including contrast sensitivity (Hammond et al., 2012 and Loughman et
al., 2012), glare disability (Hammond et al., 2012 and Loughman et al., 2010),
temporal sensitivity function (Renzi et al., 2010), glare discomfort (Stringham et
al., 2011), and photostress recovery time (Stringham et al., 2007 and 2008). All
of these visual performance metrics were measured at central fixation.

No published studies have examined the relationship between visual
performance and MPOD at parafoveal locations where MP levels are lower. The
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objectives of this project were to explore the relationship of the MPOD spatial
profile with measures of contrast sensitivity, specifically glare sensitivity, at foveal
as well as parafoveal locations out to 60 of eccentricity in order to better
understand the role of the MPOD spatial profile on measures of visual
performance.

In pursuit of demonstrating the parafoveal relationship of MPOD and visual
performance, a novel device capable of measuring MPOD across the central 160
of retina along 8 principle meridians using customized heterochromatic flicker
photometry (cHFP) to determine MPOD (e.g., Bone et al., 2004) at foveal
eccentricities of 0o, 2o, 4o, 6o and 8o using a 1o stimulus diameter was built.
MPOD was calculated as five different values: 1) Stimulus center discrete value, 2)
Stimulus center integrated across 1o, 3) Stimulus point at highest retinal sensitivity
integrated across 1o, 4) area under the curve (AUC) using stimulus center across
16o and 5) AUC using stimulus point at highest retinal sensitivity across 16 o.

Visual performance was assessed as contrast sensitivity (CS), glare disability
(GD), relative glare disability (RGD) and intraocular scatter. CS was measured
using vertical grating stimuli presented at foveal eccentricities of 0o, 2o, 4o, 6o and
8o using a 1o stimulus diameter. GD was calculated as a difference in CS
between glare and no glare conditions (CSNo Glare – CSGlare) using the same
vertical grating stimuli presented at the same foveal eccentricities. RGD [(CS No
Glare

– CSGlare) / CSNo Glare] was calculated to isolate the glare attenuation effects
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of MPOD by controlling for CS variability among the subject sample. Intraocular
scatter was assessed through a direct compensation method using a
commercially available device. Statistical analysis of the discrete and integrated
MPOD associations with CS, GD, RGD and intraocular scatter were evaluated.

Macular Pigment Spatial Distribution
The cHFP identified reliable MPOD spatial distribution maps demonstrating a 1st
order exponential decay curve as a function of increasing eccentricity with a r 2
value of 0.886 when fit to stimulus center and a r2 value of 0.907 when fit to
stimulus point at highest retinal sensitivity. Correlation values at each foveal
eccentricity were highly significant (2o r = 0.955-0.968, p<0.001 / 4o r = 0.9280.947, p<0.001 / 6o r = 0.875-0.929, p<0.001) suggesting symmetrical MPOD
distribution along the four measured meridians. OriginPro9 software was used to
create a Lorentzian distribution across the 16o macula for each subject. Individual
Lorentzian distributions were also integrated across the 1o stimulus diameter at
each measured retinal loci and across the 16o macula assuming both stimulus
center and stimulus point of highest retinal sensitivity. Kurtosis calculations for
each MPOD spatial distribution were calculated showing a range of -0.763
(highly platykurtic) to 7.154 (highly leptokurtic). Although overall MPOD spatial
distribution shows a Lorentzian distribution, substantial variability exists among
individual distributions.
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Contrast Sensitivity and Glare Disability across the Macula
CS and GD were measured and RGD was calculated at 0o, 2o, 4o and 6o of
foveal eccentricity for vertical grating stimuli of 3, 6 and 9 cycles per degree (cpd)
along nasal, temporal, superior and inferior meridians. CS for all three spatial
frequencies showed consistent trends as a function of eccentricity. Stimuli at
3cpd showed the highest CS with the lowest variability at all retinal loci
measured. Stimuli at 9cpd showed the lowest CS with the highest variability at all
retinal loci measured. Among all spatial frequencies measured, significant
differences between horizontal and vertical meridians were identified. GD
showed a general trend with increasing foveal eccentricity. At each spatial
frequency, GD increased as a function of increased foveal eccentricity with more
subjects following the expected trend using 9cpd stimuli (25 of 33 subjects) than
3cpd stimuli (21 of 33 subjects). When glare attenuation effects were isolated by
calculating RGD, the trend of increasing RGD as a function of increased foveal
eccentricity was higher using 9cpd stimuli (28 of 33 subjects) than 3cpd stimuli
(24 of 33 subjects) supporting a possible influence of spatial frequency on
resulting RGD.

Relationship between MPOD, CS, GD and Intraocular Scatter
Overall, no significant correlation between MPOD and CS was demonstrated
using 3, 6 or 9cpd stimuli. Quartile analysis of CS at 0o, 2o, 4o and 6o using 3, 6
and 9cpd stimuli showed non-significant differences between the highest and
lowest peak foveal MPOD values.
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Using 3cpd stimuli, non-significant correlations were demonstrated between peak
foveal measures of MPOD and both GD and RGD at 0o, 2o, 4o and 6o of foveal
eccentricity. Non-significant correlations were also found between corresponding
retinal loci of calculated MPOD and both GD and RGD (i.e. 2o MPOD vs. 2o GD
and RGD). However, quartile analysis found significant differences at 2 o and 4o
RGD between the highest and lowest peak foveal MPOD values.

Using 6cpd stimuli, significant correlations were demonstrated between peak
foveal measures of MPOD and RGD at 0o and 2o of foveal eccentricity. Nonsignificant correlations were found between corresponding retinal loci of
calculated MPOD and both GD and RGD. Quartile analysis found significant
differences 0o, 2o and 4o RGD between the highest and lowest peak foveal
MPOD values.

Using 9cpd stimuli, significant correlations were demonstrated between peak
foveal MPOD measures and GD at 0o and 2o foveal eccentricities and RGD at 0o,
2o and 4o foveal eccentricities. Significant correlations were also identified
between corresponding retinal loci of calculated MPOD measures and both GD
and RGD at 2o and 4o foveal eccentricities. Quartile analysis found significant
differences 0o, 2o and 4o GD and RGD between the highest and lowest peak
foveal MPOD values.
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Intraocular scatter correlations between peak foveal MPOD measures and
integrated MPOD across 16o macula demonstrated non-significant values.
However, quartile analysis of intraocular scatter showed a significant difference (t
= -2.715, p=0.015) between the highest and lowest peak foveal MPOD
measures.

In summary, peak foveal MPOD revealed the highest correlation coefficients with
RGD using 9cpd stimuli. These results possibly support a spatial frequency
association on the glare attenuation effects of MP. Further support of a spatial
frequency association may be seen form the significant correlations between
corresponding parafoveal MPOD measures and both GD and RGD at 2 o and 4o
of foveal eccentricity. Additionally, all calculated measures of peak foveal MPOD
shared similar significant correlation coefficients with both GD and RGD using
6cpd and 9cpd stimuli. These results indicate that discrete and integrated
measures of MPOD are similar in regards to their association with glare
attenuation effects across the macula. Intraocular scatter resulting from incident
light is primarily induced at the cornea and lens before reaching the retina. The
ocular media influences prior to absorption by MP are the likely explanation for
non-significant correlations between peak foveal MPOD measures and 16o
integrated measure across the macula with intraocular scatter. However, the
significant differences in intraocular scatter values between the highest and
lowest peak foveal quartiles indicate MPOD may minimize scattered intraocular
short-wavelength light albeit to a lesser degree than the cornea and lens.
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I. MACULAR PIGMENT
A. Composition and Anatomic Location
Macular pigment (MP) is the shared name for 3 isomeric carotenoids: lutein (L),
zeaxanthin (Z), and meso-zeaxanthin (MZ) which characterizes roughly 36%,
18%, and 18% of total retinal carotenoid content, respectively (Beatty et al.,
1999). The remaining 28% of macular carotenoids are comprised of metabolic
isomers including 3’-oxolutein and 3-methoxyzeaxanthin (Landrum et al., 1997).
The level of carotenoids comprising MP within the retina rises more than 1000X
above levels found in serum (Landrum et al., 1997), suggesting a specific role in
human vision.

MP is distributed across the retina with a peak density in the central 10 of the
macula with an exponential decay function falling to optically undetectable levels
around 8o of foveal eccentricity (Hammond et al., 1997). Trieschmann et al.
(2008) found that the density and distribution of MP differs among individuals and
that spatial distribution measurements did not show a significant relationship with
peak MP density found at the fovea. This finding may underscore the importance
that any MP measurement method must account for the density of foveal MP
levels as well as the spatial distribution profile.

Within the retina, L and Z are localized predominantly in the outer and inner
plexiform layers of the retina (Snodderly et al., 1984) and in the outer segments
of the photoreceptors (Sommerberg et al., 1999 and Rapp et al., 2000). MP
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location and distribution within the retina was later confirmed by Trieschmann et
al. (2008): L and Z are incorporated at the location of the fovea within the outer
plexiform layer, or Henle fiber layer, which is comprised of cone receptor axons
and in the parafovea within the inner plexiform layer of the retina. Gass et al.
(1999) postulated that a layer of Müller glial cells exists between the internal
limiting membrane and the Henle fiber layer specifically at the base of the foveal
depression. Recently, work performed by Reichenbach et al. (2013) identified a
relationship between Müller glial functions and MP deposition and transport
within the central macula. A paper published by Westrup et al. (2014) posited
that it is an association between Müller glial cells in the foveola and cone axons
in the fovea extending to the macula which produces the spatial distribution
pattern of MP.

L is found in greater levels within the peripheral retina as the ratio of L:Z changes
from approximately 1:2.4 at the fovea to 1.8:1 in the parafovea to 2.7:1 in the
peripheral retina (Bone et al., 1988 and Bone et al., 1997). The inversion of the
L:Z ratio with eccentricity parallels the rod:cone ratio demonstrated by Osterberg
(1935) and Curcio et al. (1990) suggestive of a possible underlying process
which promotes structure-specific accumulation (Bone et al., 1988). Bone et al.
(2007) suggested that MP spatial distribution is highly correlated with cone
photoreceptor distribution possibly indicating a role in cone function. Nolan et al.
(2008) proposed that foveal anatomical structure directly influences L and Z
distribution. Their results found that foveal levels of MP integrated under the
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spatial distribution curve shared a significant relationship with foveal width
measured as both foveal crest to foveal crest (r = 0.32, p <0.05) and absence of
nerve fiber layer (r = 0.41, p<0.01). Westrup et al. (2014) hypothesized that the
density differences of photoreceptor axons at the foveal center versus the
parafovea underlies the spatial distribution pattern of MP. Their findings support
that the foveal peak of MP is due to the Müller glial cells and the spatial
distribution decline of MP is a result of the higher density of photoreceptor axons
within the Henle fiber layer creating an integration of two structures incorporating
L and Z: Müller glial cells in the foveal center and the Henle fiber layer in the
parafovea producing a monotonous, exponential decline with eccentricity.

Proposed xanthophyll-binding proteins demonstrating a presence in cones as
well as rods were explored by Handelman et al. (1991). Their findings supported
a L and Z specific deposition process within primate retinal tissue using high
performance liquid chromatography techniques compared against
microdensitometry. Bhosale et al. (2004) confirmed a selective biologic
mechanism in Z integration within the retina. Their work demonstrated the piisoform of glutathione S-transferase (GSTP1) as a Z-specific binding protein
showing the highest levels within the outer and inner plexiform layers of the
human retina. Bhosale et al. (2009) identified and later confirmed by Li et al.
(2011), a membrane-associated lutein-binding protein (StARD3) and showed
specific presence of this lutein-binding protein within the rod and cone inner
segments along with an increased occurrence within the Henle fiber layer.
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The only other xanthophyll existing at substantial levels within the macula region
is meso-zeaxanthin (MZ) (Bone et al., 1993 and Landrum et al., 2001). MZ is a
stereoisomer of zeaxanthin that is not found in significant amounts within a
traditional Western diet and is not readily detectable in the serum through
conventional HPLC assays. Bone et al. (1997) proposed that a process may be
found in cone axons which may allow L to undergo isomeric conversion to MZ
and was later confirmed by Bhosale et al. (2007) demonstrating that MZ is a
metabolic isomer of L in primate models. This pathway may help to explain the
prevalence of Z relative to L at the fovea supported by a nearly 1:1
foveal:peripheral ratios of (L+MZ)/Z originally identified by Bone et al. (1997).

L and Z are not produced de novo and therefore only available through dietary
intake. The bioavailability of xanthophyllic carotenoids depends on their chemical
matrix within the dietary source and ester bonds at xanthophyll hydroxyl groups
(Schalch et al., 2007). A number of studies have evaluated the MP response to
oral supplementation with L and Z (Bone et al., 2003, Schalch et al. 2007,
Trieschmann et al., 2007, Richer et al., 2011). Although serum levels of L and Z
generally correlated with MP, differences in retinal L and Z concentrations within
the population may offer further support of specific physiologic pathways that
regulate the retinal uptake of L and Z. For example, L is the dominant xanthophyll
relative to Z in almost all food sources with only a few rare exceptions including
orange and red peppers (Perry et al., 2009). However, studies have shown that
this abundance of dietary L is almost never reflected within central retinal
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measures of MP (Bone, 1997). It is likely that individual metabolic processes
such as specific protein binding, serum lipoprotein profiles and body composition
account for the L and Z levels of MP distribution.

B. Function
Proposed functions of MP are derived from the anatomical characteristics and
the specific biochemical structure of L and Z. The effects of L and Z on short
wavelength (SW) visible light absorption and their respective antioxidant
properties have been investigated in a number of studies. Within the realm of
current literature, three primary roles for the function of MP have been described:
Protection, Optical, and Neural Efficiency. All three proposed functions derived
their hypotheses directly from structural attributes and physiological
characteristics MP.

1. Protection Hypothesis
The proposed protective hypothesis of MP depends upon its chemical structure
as well as its spectral absorption properties. Carotenoids in general are
recognized for their antioxidant and free radical scavenging properties (Krinsky,
1989). The exact pathogenesis of age related macular degeneration remains
uncertain although current models implicate a combination of cumulative damage
from reactive oxygen intermediates (ROIs) created through metabolic processes
and high energy, short wavelength light and chronic inflammation (Hollyfield et
al., 2008). O’Connell et al. (2006) provided a review of the two primary roles of
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macular carotenoids of specific importance in terms of their recognized tissue
protective effects: 1) Antioxidant function and 2) SW light filtration.

Antioxidant Function
Carotenoids, including L and Z, have demonstrated the ability to reduce singlet
oxygen (Krinsky et al., 1989), moderate ROIs (DiMacio et al., 1989), inhibit cell
membrane perioxidation (Lim et al., 1992) and reduce lipofuscin formation
(Sundelin et al., 2001). The presence of L and Z within the photoreceptor outer
segments and retinal pigmented epithelium offers further support of the ROI and
singlet oxygen reducing properties of MP (Sommerburg et al., 1999 and Rapp et
al., 2000).

Khachik et al. (1997) were able to provide the first evidence of oxidative products
of MP within retinal tissue indicating metabolic oxidation-reduction events. These
results showed definitive L and Z antioxidant activity within retinal tissue. L and Z
antioxidant properties are derived from their ability to quench singlet oxygen and
inhibit peroxyl radicals (Paiva et al., 1999). These antioxidant functions are based
on the number of conjugated double bonds and hydroxyl end groups. L and Z
have been confirmed to inhibit light-induced oxidative damage within retinal
tissue (Beatty et al., 1999). Their study showed that metabolic oxidative products
including singlet oxygen, free peroxyl radicals, and ROIs are attenuated in the
presence of L and Z.
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Krinsky et al. (2003) and Stahl et al. (2003) further explored the antioxidant
mechanism of L and Z. They identified various free radicals are created under
oxidative stress conditions found in retinal tissue and of these, xanthophyllic
carotenoids show the greatest efficiency with reactions involving peroxyl radicals.
These peroxyl radicals are the result of lipid peroxidation and the free radical
scavenging abilities of L and Z attenuates the progression of damage to lipophilic
structures (Landrum, 2013). In a number of animal models, SW light exposure
may lead to the development of ROIs which have the potential to damage
biologic tissues at a molecular level and negatively affect subcellular structures,
cells and tissues (Polidori et al., 2001 and Krutmann, 2000).

Carotenoids can quench the destructive properties of free radicals by either
providing an electron to the free radical itself or incorporating the free radical into
its own molecular structure through a covalent bond to pair the single electron.
The molecular nature of the carotenoid structure attracts free radicals ultimately
providing protection from oxidative damage to cellular lipids, proteins, and DNA
(Stahl et al., 2003).

Yeum et al. (2004) furthered the understanding of the antioxidant efficacy of
xanthophyllic carotenoids. Their study, along with results from Semba et al.
(2003), identified the polar end-groups of L and Z as a primary source of their
effectiveness. These polar end-groups project outside the cell membrane into
both the intracellular and extracellular plasma allowing enhanced interaction with
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ROIs. This unique membrane insertion enhances the antioxidant properties of L
and Z within the photoreceptor outer segment which has a significant membrane
surface area subject to oxidative reactions (Semba et al., 2003). L and Z show a
high affinity to lipid containing structures and, along with their efficiency in peroxyl
radical mitigation, carotenoids may serve a critical role in cell membrane
protection and oxidative damage (Stahl et al., 2005).

Short Wavelength Light Filtration
SW light damage at high intensity within the retinal tissue has been extensively
documented (Ham et al., 1976). At wavelengths of 450nm, nearly 100X less
energy is required to produce retinal injury compared to wavelengths greater
than 590nm. Ham et al. (1979) demonstrated the severity of light-induced injury
to retinal cells. Their work revealed that the severity of retinal damage caused by
high energy, SW light can be expressed as a function of wavelength. They
described an exponential increase in the severity of retinal damage as the
wavelength of the source decreased. Ham et al. (1984) and Noell (1980)
evaluated a bandwidth for visible SW light induced retinal damage. Their studies
identified increased risk of retinal injury at wavelengths between 400-450nm.
This action spectrum bandwidth for SW induced damage shows considerable
overlap with the previously established absorption spectrum of MP of 400500nm.
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SW light generated by an intraocular operating biomicroscope has been
recognized to create retinal lesions that demonstrate a lesser degree of injury in
affected areas corresponding to higher levels of MP (Michels et al., 1992) and
identified macular sparing from light-induced retinal lesions relative to
surrounding non-macular retinal tissue (Jaffe et al., 1988).

Snodderly et al., (1984a) proposed three reasons that L and Z are capable of
providing an optical filter of SW visible light: 1) the absorbance spectrum of
macular pigment has a peak at 460nm which falls within the short wavelength
portion of the visible light spectrum. 2) MP is at its highest levels within the cone
axon layers (primarily Henle’s fiber layer) of the retina. This prereceptoral
anatomic location allows MP to employ its absorptive properties on SW visible
light prior to incidence on the photoreceptors. 3) MP is found not only within the
axon layers of the retina but also within the outer segments of the photoreceptor
membrane itself. The presence of MP within the photoreceptor membranes may
provide additional SW light optical filtration to adjacent cells as a result of the
anatomic path followed by the axon projection to more anterior layers (Whitehead
et al., 2006). Using the absorbance formula applied with spectroscopy
measurements [A=log10(Io/I)], Snodderly et al. (1984b) postulated that macular
carotenoids are capable of decreasing incident blue light by approximately 40%,
assuming their study sample mean central MPOD.
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Sujak et al. (1999) demonstrated that L and Z are incorporated into the liposome
bilayer at different orientations. Z was identified in a vertical orientation with
respect to the membrane layer while L was incorporated in both a vertical and
horizontal orientation. Differences in both SW absorption and antioxidant
properties may be attributed to these differences in orientation. Junghans et al.
(2001) identified L as a superior filter of SW light relative to Z. They posited that
the higher optical filtration efficiency of L was a result of the both parallel and
perpendicular orientations found within photoreceptor membranes compared to Z
which has only a perpendicular membrane orientation. A likely result of the two
orthogonal orientations of L within the lipid membrane is an improved capture of
incident SW light. L and Z are located in an anatomically ideal location to
attenuate incident SW light and may preclude the photosensitization of retinal
tissue and the formation of ROIs. The SW attenuation provided by L and Z can
be viewed as an indirect protective function (Bernstein et al., 2010).

The Protection Hypothesis is comprised of two primary elements: antioxidant
functions and SW light filtration. These two elements are not mutually exclusive
and likely act in a synergistic fashion. Clinical conditions resulting in annular
maculopathy including maculopathy resulting from use of photosensitizing drugs
are described by central retinal degeneration in an annular pattern which
surrounds but spares the 1o foveal region corresponding to the diameter of
highest MPOD (Weiter et al., 1988). Foveal sparing may be a result of the free
radical scavenging and oxidative damage inhibition properties demonstrated by
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MP. Foveal sparing has also been documented in advanced cases geographic
atrophy associated with AMD (Schatz et al., 1989 and Sunness et al., 1999).

Haegerstrom-Portnoy (1988) published results documenting a loss of SW cone
sensitivity with age. Their study identified less SW sensitivity loss in the fovea
where MP is at the highest levels compared to non-foveal areas. Hammond et al.
(1998) also found photopic sensitivity was related to MP in subjects aged 60-84
years. Their study demonstrated a significant relationship for both 550nm
(p<0.01) and 440nm (p<0.001). However, older individuals (ages 60-84) with the
highest levels of MP had visual sensitivity levels that were not significantly
different from younger individuals (ages 24-36). Older individuals with the lowest
levels of MP had significantly different visual sensitivity levels than younger
subjects. Their results support a visual sensitivity relationship and suggest that
potential retinal protection may be offered by MP.

A case-control study performed by Bone et al. (2001) utilized donor retinas from
56 individuals diagnosed with age-related macular degeneration (AMD) and 56
control donors without evidence of AMD. Three concentric regions of retina, an
inner region of 0° to 5°, a middle region of 5° to 19° and a peripheral region of
19° to 38° were analyzed for L and Z concentration using high performance liquid
chromatography (HPLC). The differences in L and Z content between controls
and AMD donors were greatest at the inner region and decreased with
eccentricity. A logistic regression analysis showed that individuals with the
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highest levels of L and Z concentrations had an 82% risk reduction for AMD than
those with the lowest levels when controlling for both age and gender. The Lutein
Antioxidant Supplementation Trial (LAST) (Richer et al., 2004) was one of the
first large scale prospective placebo controlled trials to identify a significant link
between AMD, lutein supplementation, and visual performance. Treatment
groups received one of three possible conditions: lutein, lutein plus antioxidants
or a placebo. MPOD measured at the end of a 12-month trial showed a mean
increase of nearly 0.09 optical density units from baseline measurements and
improved visual acuity as well as contrast sensitivity. The NIH-sponsored AgeRelated Eye Disease Study 2 (AREDS2) is the largest multi-center, longitudinal,
placebo-controlled, randomized clinical trials performed using lutein and
zeaxanthin supplementation. The study encompasses 2 of the 3 hypotheses of
MP by using a primary outcome measure as rate of progression to advanced
AMD (Protection Hypothesis) and a secondary outcome measure of cognitive
function (Neural Hypothesis). Results for the AREDS2 indicated a 10% reduction
in progression to advanced AMD when L and Z were added to the original
AREDS formula. When L and Z were substituted in place of β-carotene, results
identified an18% risk reduction in advanced AMD within 5 years and a 22% risk
reduction in neovascular AMD within 5 years. The authors of AREDS2
acknowledged that a potential competitive inhibition of carotenoids may have
occurred when both beta-carotene and L and Z were incorporated within the
original AREDS formulation.
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Growing evidence indicates that the Protection Hypothesis is better supported by
the shape of the MP spatial distribution rather than the MP peak density (Wenzel
et al., 2006 and Stringham et al., 2010). Peak MPOD is typically measured at the
fovea or central 10 of retina. Large variations in spatial distribution across the
remaining macula are not reported in foveal measurements which may overlook
important differences in a total integrated MP versus a single peak MP value. As
both an antioxidant and SW visible light filter incorporated into the photoreceptor
axon membrane, L and Z would likely confer greater benefits distributed across
the macula as opposed to a single, central, isolated peak. Evidence of an
association between MPOD spatial distribution and an increased risk of agerelated macular degeneration has been described in the literature (Kirby et al.,
2010). The characteristics of L and Z that confer protective benefits in retinal
disease may be the same characteristics that are able to confer optical benefits
to both foveal and parafoveal areas.

2. Optical Hypotheses
The origins of the Optical Hypothesis were first posited by Walls and Judd (1933)
in reference to ‘oil-droplet filters of a carotenoid nature’ which were associated
with cone photoreceptors. The ellipsoid containing the oil droplet is located at the
distal end of the inner segment which covers the outer segment. This positioning
allows a majority of incident light to pass through it before reaching the visual
pigment. Later, Nussbaum et al. (1981) advanced the Optical Hypothesis in
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which MP is specifically referenced. Both summaries shared common ideas for
the principle functions of an “Optical Hypothesis”. These principle functions are:

1) The improvement visual acuity by a reduction of chromatic aberration
2) The promotion of comfort by a reduction of glare
3) The improvement of detail by atmospheric blue-haze absorption
4) The enhancement of contrast by selective short wavelength light attenuation

Separate, but not mutually exclusive from the Protection Hypothesis, the Optical
Hypothesis posits MP filters SW visible light causing an attenuation of chromatic
aberrations and SW light scatter. Related to the SW attenuation properties, MP
has been described as a dichroic filter exhibiting selective absorption of plane
polarized light.

The primary focus of the Optical Hypothesis is the theory that MP enhances
visual potential through optical filtration effects due to its pre-receptoral location
within the inner layers of the macula. The multi-faceted theory of the Optical
Hypothesis of MP encompasses several mutually dependent physiological and
optical roles. In general, the Optical Hypothesis can be broken down into
separate, interrelated components: the Acuity Hypothesis, the Glare Hypothesis,
and the Visibility Hypothesis.
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i. Acuity Hypothesis
Engles et al. (2007) provided a review of the origins of the Optical Hypothesis.
First formally proposed in 1866 by German anatomist Max Schultze, the Optical
Hypothesis postulated that MP may enhance visual acuity by facilitating a
reduction of short wavelength aberrations through absorptive properties.
Schultze contended that the selective wavelength absorption of MP helped to
limit chromatic aberration. Discussed as the “Acuity Hypothesis” by Wooten et
al. (2002), it was been proposed that MP improves acuity by screening both
scattered and aberrated SW visible light that would otherwise degrade image
quality.

The first empiric measurements to review Shultze’s theory were conducted by
Reading and Weale (1974). They initially calculated the resulting blur circle due
to the chromatic aberration of natural sunlight. Using the derived aberration data,
they were able to derive the spectral transmission of an ideal filter that would
diminish the SW portion of visible light to near threshold levels at the same time
maximizing remaining light transmission. The resulting transmission
characteristics closely resembled the spectral absorption of MP. Reading and
Weale then used the resulting filter combined with psychophysical data
associated with chromatic aberration and visual thresholds. From this, they
determined levels of macular pigment sufficient to decrease the violet (SW)
portion of a white disc to subthreshold levels and theoretically improve visual
acuity.
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Campbell and Gubisch (1966) also measured visual acuity using broadband light
versus monochromatic light under photopic conditions and found that chromatic
aberration accounts for ~50% of the variance between physical and
psychophysical assessments of the human eye’s optical quality. Yoon and
Williams (2002) repeated the Campbell and Gubisch experiment using strict
controls and measuring acuity as well as contrast sensitivity. Their results
demonstrated that at spatial frequency greater than 6cpd, using narrow-band
light increased acuity measurements by a factor of approximately 1.2-1.5.
However, neither experiment measured associated MPOD. Therefore, if normal
optical density of a subject is assumed, the initial contention of Reading and
Weale (1974) is supported and any additional reduction in SW visible light would
be largely superfluous and additional improvement in visual acuity would be nonsignificant. This same interpretation has been documented in numerous studies
that document specific bandwidth filters (e.g. yellow filters) in general, may
improve contrast sensitivity and decrease glare but do not improve spatial
resolution (Wooten et al., 2002 and Eperjesi et al., 2002).

Engles et al. (2007) reviewed chromatic aberration effects and summarized that
refractive error with a wavelength dependence will affect retinal image quality of
a polychromatic stimulus to the greatest degree at wavelengths below 500nm.
The authors cited Howarth et al. (1986) which stated SW light defocus can reach
1.6D at 420nm and approximately 1.2D defocus at 460nm. The characteristics of
chromatic aberration are wavelength dependent image degradation (e.g.
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longitudinal chromatic aberration) and wavelength dependent image position
(e.g. lateral chromatic aberration). Each of these components decreases the
retinal image quality, however; longitudinal chromatic aberration tends to be the
dominant component in a typical eye. Empirical studies performed by Kaiser
(1988) show that for each additional diopter of retinal image degradation, visual
acuity falls by a factor of nearly two.

Engles et al. (2007) created an empiric evaluation of the Acuity Hypothesis by
direct comparison of macular pigment optical density and both resolution acuity
and hyperacuity. Previous studies (Yoon et al., 2002 and Wooten et al., 2002)
had evaluated resolution acuity but Engles et al. extended the hypothesis to
include hyperacuity. The authors’ position to include hyperacuity was that it
characterizes the highest level of spatial discrimination and may be the first to
exhibit improvements with the elimination of image degradation. Their study
utilized solid black targets presented on a white background with a peak
wavelength of 460nm or a yellow background with a peak wavelength of 570nm.
Results revealed no significant correlations between MP and acuity, either
resolution or hyperacuity, in either background condition. Engles et al. also
evaluated a standard observer’s V(λ) curve as it related to optical defocus
centered on 565nm. They found only a 12% difference in defocus of greater than
0.25D in the 430nm to 510nm region. The authors concluded that macular
pigment is not related to resolution acuity or hyperacuity.
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ii. Glare Hypothesis
The human visual system is adept at detecting at luminance levels that span
approximately 8 orders of magnitude (e.g. Pokorny et al., 2006). Retinal
adaptation adjusts the range of visual sensitivity to prevailing luminance.
Perceptual difficulties occur when the visual system must adapt to changes
across this range. Glare is caused by light entering the eye that does not aid
vision and is most commonly luminance that is too intense or variable across the
visual field (Mainster et al., 2012). Glare can be evaluated as three distinct forms:
disability glare, discomfort glare and dazzling glare. Vos (2003) provides a
comprehensive review of the types of glare.

Disability Glare
Disability glare has been defined as loss of retinal image contrast resulting from
veiling illuminance or intraocular scatter. Decreased visual performance follows
the loss of retinal image contrast as a consequence of increased forward scatter
within the eye. Diminution in visual potential may result from both veiling
illuminance that reduces the object contrast as well as photopigment depletion
and regeneration rates. The origins of disability glare support a dependence on
the overall luminance and wavelength created by a glare source (Aslam et al.,
2007). Forward scattering or straylight is not the primary cause of disability glare
symptoms in all cases. At smaller angles of incidence, neural inhibition at the
level of the retina can add to disability glare through retinal gain models (van den
Berg et al. 1991).
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Increased MPOD will not affect glare disability when the wavelength of the
stimulus and the wavelength of the background are the same (Stringham et al.,
2007). If MP absorbs SW light from the stimulus and background in equivalent
amounts, the ratio will remain comparable regardless of the MP density level. In
this instance, high MPOD may diminish visual discomfort but it will not increase
stimulus visibility (Renzi et al., 2010a and Wenzel et al., 2006). Strictly speaking,
MP filters the veiling luminance of the target at the retinal plane proportional to
the MPOD for SW light.

Discomfort Glare
Discomfort glare has been characterized as exacerbation or generation of pain
as a consequence of light exposure which does not necessarily impair object
visibility. Digre and Brennan (2012) defined photophobia as ‘a sensory state in
which light causes discomfort in the eye or head possibly involving an avoidance
reaction without overt pain’. The authors also drew a distinction with the term
photo-oculodynia used to describe light-induced pain from a normally non-painful
source such as ambient lighting. According to Lapid-Gortzak et al. (2011),
clinical complaints of photophobia resulting from a small posterior capsulotomy
following a cataract procedure were associated with increased straylight values.
The authors concluded that, in some case, photophobia may be a result of
increased intraocular scatter.
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Stringham et al. (2003) and Stringham et al. (2004) evaluated the effects of MP
on glare discomfort. Together these two studies showed the degree of visual
discomfort was significantly higher if the glare source contained SW light
compared to mid and long wavelength visible light. Their results further identified
that in subjects with higher levels of MPOD, a greater intensity of SW light was
required to produce an avoidance response. In retinal eccentricities greater than
100 where MP levels are non-significant, significantly less intensity of SW light
was required to elicit the same avoidance response.

Dazzling Glare
Dazzling glare is a form of discomfort glare associated with disability glare.
Sheehy (1989) reported the loss in visual performance resulting from
wavelengths within the visible spectrum and detailed the characteristics of eye
protection necessary based on visual performance. It is commonly encountered
as high retinal illuminance across the visual field in scenarios such as expanses
of snow or water and facing the sun when it is low in the horizon (Vos 2003).
Dazzling glare typically results in a light avoidance behavior and is related to
photostress (high retinal illuminance leading to bleaching of photopigments,
afterimages and temporary, reduced retinal sensitivity) and scotomatic glare
(transient visual disturbances usually associated with minimal discomfort).

The Glare hypothesis is derived from the selective filtering properties of MP on
short wavelength light (Stringham et al., 2007). SW light as a significant
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contributor to the ocular discomfort and disability related to exposure from a glare
source has been identified in the literature (Stringham et al., 2003 and Mainster
et al. 2012). A 2007 study by Stringham et al. defined the origins of disability
glare as the ‘forward scattering of light resulting from illumination at the retina
that directly reduces image contrast ’. Their results supported a significant
dependence of disability glare on the overall luminance created by a glare
source. Stringham et al. inferred that the global effects produced by MP optical
filtration are greater under broadband, achromatic light sources in contrast to
narrow-band SW light sources. Importantly, Stringham et al. (2007) recognized
that MP effects on glare disability result from the spectral characteristics of the
light source. Their technique involved the use of a 10 grating with a spatial
frequency of 5cpd at 100% contrast as a central stimulus. A xenon arc annulus
with an inner diameter of 11o was adjusted by the subject and the radiance of the
glare source was recorded when the subject reported that the grating was no
longer visible. Their findings demonstrated significance at 440nm (r = 0.36, p =
0.032) and 460nm (r = 0.34, p = 0.039) but non-significance at 550nm and
580nm. Overall, the authors were able to explain 58% of the variance of target
visibility through subject differences in MPOD. MP will not decrease glare
disability if the source does not contain a substantial amount of SW visible light
(Stringham et al., 2007).

These studies support the idea that MPOD plays a role in visual discomfort due
to glare reduction but do not address whether improvements in visual
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performance occurs. Stringham and Hammond et al. (2007) performed an
empiric study of both photostress and glare disability as they relate to MPOD.
Their results revealed a significant correlation of visual thresholds under glare
conditions with MP density (r = 0.76, p<0.0001) and photostress recovery time,
after exposure to xenon-white light, was significantly lessened for subjects with
higher MP levels (r = -0.79, p<0.0001). Results of the study also found that MP
displayed a stronger correlation coefficient to both glare disability and
photostress recovery in the broadband white testing conditions compared to
narrow-band short-wavelength light.

iii. Visibility Hypothesis
The Visibility Hypothesis has its origins from Luria (1972) who demonstrated that
resolution threshold for a yellow stimulus on a blue surround is improved when
observed through SW-selective filters. The result was later confirmed by
Wolffsohn et al. (2000) using contrast sensitivity measurements. A SW specific
filter reduces the luminance of blue backgrounds resulting in increased visibility
of the yellow stimulus.

The basic theory of the visibility hypothesis was summarized by McCartney
(1976). At every point along a line of sight to a point on a distant object, light
reflected from the object will interact with particles within the atmosphere and
consequently increase light scatter towards the observer. Husar et al. (2000)
suggested that, separate from the optical and neurological status of the subject,
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scatter due to atmospheric composition is the primary determinant of visual
discrimination and range at large distances.

Visibility was defined by Wooten et al. (2002) as the clearness with which objects
in the atmosphere stand out from their surroundings. It is the atmospheric
composition that guides the visibility hypothesis when considering the physics of
light scatter. Light scattering results from particle interactions that occur along an
electromagnetic wave path that simultaneously removes energy from the incident
wave and emits that energy at a solid angle from the particle. Scattering only
occurs when the particle’s refractive index differs from the surrounding medium
(e.g. smog, haze, and vapor). The amount of scatter depends on the particle type
and concentration within the atmosphere. This particle-dependent scatter largely
dictates the quality of vision in an outdoor environment. Rayleigh (elastic / small
particle) and Mie (inelastic / large particle) scattering are essential theories for
describing the effects SW light within the environment (Wooten et al., 2002).

If scatter within the eye is wavelength dependent as it is in the clear atmosphere,
then MP may increase the resolution of the retinal image by selectively screening
the highly scattered SW visible light. Straylight from the cornea and lens
increases with decreasing wavelength showing a Rayleigh type of scattering (van
den Berg, 1997) and straylight from fundus reflectance and transillumination
decreases with decreasing wavelength (van den Berg et al., 1991). Coppen et al.
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(2006) suggested the presence of significant forward scatter of SW light and
relatively less backward scatter of SW light to be absorbed by MP.

The Visibility Hypothesis posits that the resolution of a distant object is affected in
primarily two ways: 1) Light reflected from an object demonstrates increased
scatter along the sight path and 2) Background light energy is scattered into the
eye, not directly reflected from the target. Considering the object’s visibility
against the horizon, an underlying theory of the Visibility Hypothesis suggests
that atmospheric scattering reduces the relative contrast of objects (Wooten et
al., 2002). Wavelength dependence of object background and wavelength
dependence of object are critical components of determining MP influences on
the scatter resulting from atmospheric particle interactions referred to as the
atmospheric haze coefficient by Wooten and Hammond.

Wooten et al. (2002) summarize the mathematical derivation of the atmospheric
haze coefficient by integrating the CIE photopic luminosity function and the
spectral energy of the natural illuminant. They proposed that the non-image
forming portion of atmospheric light acts as a veiling luminance with respect to
the targets seen through it. In addition, Rayleigh scattering influences the
atmospheric background wavelength causing SW light to become the dominant
wavelength as the viewing distance increases. MP absorbs wavelengths
primarily in the 410-520nm range and will have a quantitatively different effect on
the SW dominant background versus object wavelength (Snodderly et al., 1984).
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The increased retina image resolution described by the Visibility Hypothesis may
have its origins in the dichroic properties of MP due to its fundamental anatomic
orientation features. Linear dichroism is defined as a difference in absorption of
light linearly polarized parallel and perpendicular to an orientation axis (Bengt,
1997). In a 1980 paper, Bone briefly reviewed existing experimental evidence
that partial symmetry of L orientation within the retina was created dichroic
properties. His work proposed a ‘dichroic ratio’ investigating the absorption of
incident polarized light parallel and perpendicular to the molecule axis. The
presence of linear dichroic properties exhibited by the MP supports that a portion
of the L orientation must be arranged tangential with respect to the fovea
(Mission, 1993). Bone et al. (1985) speculated that Haidinger’s brush
phenomena are a result of the dichroic properties of L and Z. These identified
dichroic properties are likely derived from the perpendicular arrangement of Z
and the non-orthogonal positioning of L within the lipid membrane layer
referenced above (N’Soukpoe-Kossi et al., 1988). Work by Hemenger (1992)
agreed that MP exhibits these dichroic properties and may reduce glare disability
through selective absorption of polarized light. Sujak et al. (2000) provided
further support that the cone axons projections from the central fovea to form the
outer plexiform layer or Henle fiber layer causes both L and Z to display dichroic
properties. The perpendicular membrane orientation of both L and Z within the
radial projections of the Henle fiber layer may allow specific absorption of planepolarized light.
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3. Neural Hypothesis
L and Z have been studied extensively for their roles in singlet oxygen
scavenging and ROI neutralization within retinal tissue (Krinsky et al., 1989 and
Khachik et al., 1997 and Paiva et al., 1999). L and Z models have proposed antiinflammatory properties through modulation of lipoxygenase activity and
decrease oxidative stress in high metabolic environments including the RPE
(Krinsky et al., 2005).

Anatomically, the retina is an extension of the brain consisting of axons which
form the optic nerve and project to both cortical and subcortical locations. Like
the CNS, the retina also displays physiologic and immune responses similar to
those found within the brain. The brain, like the retina, is susceptible to lipid
peroxidation, increased production of ROI and increased levels of oxidative
stress as a result of a high metabolic rate. Craft et al. (2004) identified that
approximately 66-77% of the total carotenoids found in the brain were L and Z.
These concentrations of L and Z were highest within the pons and medulla and
cortical structures such as the frontal and occipital lobe. The preferential
accumulation of L and Z within CNS tissue supports a potential role in neural
function.

Vishwanathan et al. (2012) assessed a primate model of the retinal L and Z
levels compared to brain L and Z levels. Their findings showed retinal L was
significantly associated with levels of L in the pons, cerebellum and occipital
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cortex with marginal significance in the frontal cortex. Macular Z was significantly
associated with levels of Z in the cerebellum and frontal cortex with marginal
significance in the pons and occipital cortex. The authors suggested that an
integrated measure of MPOD has the potential to serve as a biomarker for brain
L and Z level.

Early investigation into L and Z by Bernstein et al. (1997) showed that, within
neural tissue, L and Z accumulate at the location of the microtubules forming the
cytoarchitecture of retinal axons. Crabtree et al. (2001) identified the role of
tubulin as a potential binding protein that specifically accumulates L and Z within
axon cell membranes. Stahl et al. (2002) recognized that, in addition to structural
roles, microtubules can also influence gap junction communication and neural
transmission. Gap junction transmission is an important mediator between glial
cells and neuron within the retina propagating action potentials. Gap junction
communication has also been connected to the transfer of metabolites and
electrolytes within the sensory retina. Wieslaw et al. (2004) identified positive
metabolic effects of L and Z on the structure and equilibrium of neural
membranes through the protein lattice structures formed from tubulin. Hammond
et al. (2008) proposed that the physiologic and structural elements of L and Z
combined with their conspicuous positioning within the CNS may influence neural
processes. Zimmer and Hammond (2007) identified data showing the inverse
relationship between MP density and rod-mediated (scotopic) noise hypothesized
to originate at the level of the retina.
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Akbaraly et al. (2007) identified a link between serum levels of Z and cognitive
functioning. Using a Mini-Mental State Examination, Akbaraly et al. showed that
participants with cognitive functioning in the lowest quartile had a significant
probability of having plasma Z levels in the lowest quartile (OR: 1.97, CI:1.213.20). Johnson et al. (2008) demonstrated a significant relationship between L
and both verbal fluency and memory scores in women ages 60-80 years in a
placebo-controlled trial. Johnson et al. (2013) recognized serum L and Z were
related to cognitive function including memory, processing speed, attention, and
executive function. In brain sample, L was related lower dementia severity
(p<0.05). Feeny et al. (2013) identified lower foveal MPOD with reduced
performance in individuals over 50 years of age on a range of cognitive tasks
including the Montreal cognitive assessment (p = 0.011) and a mini mental state
assessment (p = 0.026).

Decreased L and Z serum levels have also been associated with mild cognitive
impairment (MCI) and Alzheimer’s disease (AD). Rinaldi et al. (2003) identified
decreased levels of serum L in MCI (p<0.01) and AD (p<0.0001) and decreased
levels of Z in MCI (p<0.01) and AD (0.0001). Nakagawa et al. (2011)
hypothesized that the xanthophyllic carotenoids, specifically L, may inhibit
amyloid-β damage to red blood cells and decrease the oxidative injury caused to
the brain.
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C. Measurement Methods
Widely accepted as the “gold standard” of MP measurement, high performance
liquid chromatography (HPLC) has been employed in spatial distribution and
quantitative analysis studies (Gellerman, 2004; Brown, 1990). HPLC is used
extensively within biochemistry and analytical chemistry to identify and quantify
individual components of a substance (Brown, 1990). Unfortunately, the ex vivo
nature of HPLC measurement prevents application of this technique to a clinical
population.

At the very core of an in vivo MP measurement lies the matching of spectral
absorption curves from L and Z to any method, objective or subjective. The
difficulty of this proposition is replicating the in vivo environment in an accurate,
quantifiable ex vivo situation. For example, L and Z show a change in spectral
absorption when isolated within ethanol versus lipid-rich preparations (Bone,
1985; Handelman, 1991). The orientation of these molecules also differ in their
proposed role in spectral filtration and antioxidant properties, underscoring the
importance of understanding the in vivo versus ex vivo data (Sujak, 1999).

The more recent development of in vivo techniques of MPOD measurement has
shown great promise using both objective and subjective methods. Objective
methods include fundus reflectometry, fundus autofluorescence, resonance
Raman spectroscopy, and visually evoked potentials (Howells, 2011). Each of
these techniques share the common advantage that all objective measurements
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share: Objective results that require minimal patient participation. However, the
previously listed objective measurement devices also share significant
disadvantages such as minimum required pupil diameter, media opacity
considerations (lens clarity), imaging artifacts, need for retinal bleaching to limit
photopigment absorption, significant expense and, in the case of resonance
Raman spectroscopy, no comparative data (Hammond, 2005).

Subjective methods of in vivo MPOD measurement are also commercially
available. These include threshold spectral sensitivity, color matching, dichroismbased measurements, minimum motion photometry, apparent motion
photometry, and heterochromatic flicker photometry (HFP) (Hammond, 2005).
Threshold spectral sensitivity targets the difference spectrum of MP by
comparing the spectral sensitivity of the M cone mechanism in the foveal and
parafoveal region by isolating a single photoreceptor sensitivity range (Pease et
al., 1983). Color matching techniques involves two separate color matches: one
performed at the fovea and another performed at 5o of eccentricity. The
reference stimulus contains 490nm wavelength desaturated by 650nm
wavelength. The reference stimulus is then matched by combining spectral
primaries of 460nm, 530nm and 650nm wavelengths. The ratio of the 00:5o
eccentricity color match determines the MPOD (Davies et al., 2002). Dichroism
measurements rely on the partial plane polarization effects created by the shared
distribution of L and Z orientations within the retinal layers. Dichroic
measurements compare the foveal and parafoveal sensitivity against a

P a g e | 57

dichroism-based spectrum and difference measurements reflect the level of MP
(Bone et al., 1992). Minimum motion photometry and apparent motion
photometry share underlying perceptual principles: Moving square wave gratings
are creating using alternating wavelengths with one wavelength strongly
absorbed by MP and the other minimally absorbed by MP. The radiance of the
longer wavelength is adjusted by the subject until the motion appears to slow
(minimum motion photometry) or reverse (apparent motion photometry). The
square wave target is presented at foveal and parafoveal locations and a log
ratio of these values determine MPOD (Moreland, 2004).

HFP is the most common and widely studied method of measuring MP
(Hammond, 2005). Within existing literature, over 50 publications utilized HFP in
their studies of MPOD. This large collection of peer-reviewed work allows for the
scrutiny of existing assumptions and further experimental evaluation. For these
reasons, effort and resources were focused on HFP.

1. Heterochromatic Flicker Photometry
The ideal method of measuring MPOD depends on the specific application and a
consideration of the limitations and assumptions underlying the use of each
method. Preferably, the method employed should be capable of generating a
spectral curve that can be compared with ex vivo template data. Provided below
is a macular pigment spectral curve created from data by Wyszecki and Stiles
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(1982) Bone et al. (1992), Ruddock (1963), and Pease et al. (1967) identifying
optical density as a function of wavelength

Figure 1
A fitted macular pigment spectral curve created from data by Wyszecki and Stiles (1982) Bone et al. (1992), Ruddock
(1963), and Pease et al. (1967) identifying optical density as a function of wavelength.

Like many of the techniques described above, HFP utilizes the known spectral
absorption properties of L and Z in combination with the presumed anatomic
location of MP. HFP determines MPOD by presenting a stimulus of two
alternating narrowband wavelengths at the fovea and a parafoveal location. The
peak wavelengths are selected specifically to maximize macular pigment
absorption (458-476nm) and to minimize macular pigment absorption (530575nm). When the two alternating colors are presented at a proper frequency, a
dissimilar luminance of the two wavelengths will be perceived as a flickering light
with a mixture of the two source wavelengths. The radiance of the blue
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wavelength is increased by the observer until the flicker is minimized and
equiluminance of the blue and green wavelengths is achieved. This procedure is
presented at the foveal location then a parafoveal reference location to measure
a maximum of MP absorption and a minimum of MP absorption. The tenet of
HFP is dependent upon the retinal location and absorption spectra of macular
pigment. MP has peak absorption at 460nm and demonstrates its highest density
at the fovea diminishing with eccentricity at ~7o where negligible MP is identified
through HPLC. Using this approach, a greater intensity of blue light will be
required at the fovea where MP is the highest relative to a parafoveal location.
The log ratio of blue light radiance at the fovea compared to parafoveal location
is the measured MPOD.

One type of HFP device utilizes a Maxwellian optical system with a bite bar for
head stabilization. These complex designs require considerable training to
operate and require considerable training associated with their set-up. Freeviewing devices have offered an alternative to the more complex Maxwellian
system. Several studies has established the strong correlation between device
results and determined that accuracy is not compromised (Wooten, 1999 and
Beatty et al., 2000).

Of critical importance to measurement procedures are size of the testing fields,
flicker rates of stimulus, and background luminance. First, the testing field is
viewed a near-working distance using a 1o central stimulus. Exceptions to these
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parameters exist but all fall within a similar range. The stimulus wavelength is
determined to maximize MP absorption centered at 460nm and deviation from
this peak must be corrected for during final determination of MPOD. Bandwidth of
stimulus source may also be adjusted recognizing that the more narrow the
bandwidth, the more accurate the MPOD measurement but at the cost of
luminance. In the first HFP device described by Wooten et al. (1999), the LED
source with peak energy at 458nm had a half-bandwidth of 20nm. As a result, the
measured MPOD was corrected by a 15% constant. Parafoveal reference
locations used by HFP devices range from 4o (Hammond, 200) to 12o (Werner,
2000) eccentric from the fovea. As alluded to above, the parafoveal reference
locations are used under the assumption that no MP exists at these points.
Accurate selection of the parafoveal retinal locus is critical for accurate MPOD
measurement. Negligible MP has been identified at outside 7o of eccentricity by
HPLC (Bone, 1992). Incorrect assumption of absent MP will lead to significant
underestimation of true optical density.

Secondly, the selected flicker rates for alternating blue/green wavelength
stimulus rely on individual subject’s flicker sensitivity. If flicker rate is set too low,
the subject will have trouble correctly identifying a point of null flicker. If the flicker
rate is set too high, the subject will show a large range of null point variability
creating variations in measurements. Ideally, the approach is to create a
repeatable, customized flicker rate for each subject at both the foveal and
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parafoveal locations. Parafoveal reference locations employ the same flicker
stimulus with a properly calibrated flicker rate for a non-foveal point.

Finally, the background field that the stimulus is presented upon must both
suppress the S-cone contribution and provide photopic conditions in order to
suppress rod pathway interaction. Previous designs have utilized either a blue
wavelength background or high luminance white background. The size of the
background field that the stimulus is presented upon has also been reported in
the literature from 4o to 30o. Small background fields of 4o present difficulty when
parafoveal reference points require at least 7o of eccentricity to ensure absent
macular pigment. Large fields of 30o however, present their own challenges with
subject accuracy and sensitivity to a 1o stimulus within a high luminance field.

Interference of MPOD measurement from ocular media absorption or scattering
is controlled in HFP by using the parafoveal reference location. For example,
crystalline lens brunescence would influence MPOD values but is controlled for
by using the equally-affected measure outside the fovea during calculations.
Unequal intrasubject retinal distribution of L and M photoreceptors and their
differing spectral sensitivities are also controlled for through an invariant
background field with a superimposed stimulus measured at a foveal and
parafoveal location.
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II. Visual Performance
A. Spatial
Measurement of spatial visual acuity can be accomplished in several different
ways. The more conventional measurements include a confirmation of the
presence of an object (minimum visible), or the distinction between two point
sources (minimum resolvable), or the detection of the minimum offset of position
(hyperacuity) (Wyszecki and Stiles, 1982). In the case of all three measurements
of acuity, both physical and physiological factors determine visual performance.
These physical and physiological factors include the optics of the eye, the quality
of the retinal image, the structure and function of the retina, and the capacity of
the neural stages of transmission of visual information (Westheimer, 1964).

Resolution acuity (RA) is defined as the minimum perceivable angular distance
subtended by the centers of two point sources that can reliably identified as two
points as opposed to one (Westheimer, 2001 and 2003a). This threshold is
determined by at least two of the above mentioned factors: 1) Ganglion cell
packing density and receptive field convergence of the photoreceptor input and
2) the quality of the image dictated by the optical constituents of the eye.

Building on the established principle of cone receptor density and ganglion cell
convergence, Virsu and Rovamo (1979) proposed the invariance principle. They
suggested an equivalent resolution of visual stimuli existing at any point within
the visual field if the stimuli are compared in terms of cortical projection or M-
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scaled. The cortical magnification scaling, suggested by Virsu and Rovamo
(1979), is designed to balance the area of V1 neurons stimulated so that cortical
projection becomes independent of retinal location within a receptive field. The
values of calculated cortical projection used in their scaling were directly related
to the square root of retinal ganglion cell receptive field density. The orderly
composition of V1 (Hubel and Weisel, 1977) allows M-scaling to keep the
number of stimulated cortical neurons constant. Using equivalent quantities of
stimulated retinal ganglion cells and cortical cells, Virsu and Rovamo (1979)
further suggested that it was possible to generalize to other points within the
visual pathway.

The spatial modulation transfer function (SMTF) is a measure of the object:image
contrast ratio as a function of spatial frequency (Van Nes et al., 1967). Their work
determined that when longitudinal chromatic aberration effects are controlled for,
photopic contrast sensitivity function is equivalent across the visible spectrum.
Van Nes et al also reported that low retinal illuminance followed the de VriesRose Law: under dim illumination, variations inherent in a background source
largely determine threshold. At higher retinal illuminance, threshold modulation
followed the Weber-Fechner Law: As the background illumination is increased,
the intensity of the stimulus must also be increased so that the ratio of
stimulus:background remains constant.

The SMTF describes the quality of an optical image produced by an optical
system. The determination of the visual system SMTF utilizes a spatial grating
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pattern of a known contrast to serve as the object. As the light from the object
passes through the optical system, some degradation of the image occurs. The
contrast of the resulting image is measured and the ratio of object:image contrast
can be calculated. By performing this technique to a range of low to high spatial
frequencies, a SMTF is produced and is commonly referred to as the contrast
sensitivity function (CSF). Loughman et al. (2010b) reported a theoretical
improvement of resolution acuity up to 0.1 log units by correction for chromatic
aberration due to the characteristic short wavelength absorption. This theoretical
refinement is in line with earlier published work involving the limiting effects of
chromatic aberration on the SMTF (Thibos et al., 1991).

Thibos (1990) stated that an image-forming optical system exhibits chromatic
aberration if its focal length is not independent of wavelength. Although
differences in focal length among different wavelengths define chromatic
aberration, SW light appears to be the principle contributor to reduced image
quality when regarding the composition of the visible spectrum. The level of
defocus due to chromatic aberration in addition to the typical diffraction pattern
would operate in concert to widen Airy’s disc. According to the hypothesis
originally proposed by Schultze (Magnussen et al., 2001), the filtering effect MP
on SW light would sacrifice a small amount of retinal illumination for a more
narrow diffraction pattern resulting in increased contrast and potentially improved
resolution acuity.
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Engles et al. (2005a/b) used bandpass filters that provided a comparable spectral
absorption profile of the human lens and macular pigment equivalent to 0.7 log
optical density unit. Engles et al. demonstrated an improvement in visual acuity
as measured by Landolt C (2005a) and contrast sensitivity (2005b) using the
simulated SW filter under broadband illumination. Engles et al. (2007) later
performed an empiric study of the Acuity Hypothesis involving human subjects.
Using MP as a study variable and resolution and vernier acuity as visual
performance measure, their group was unable to correlate MPOD with either
resolution acuity or hyperacuity drawing the predictions of the Acuity Hypothesis
into question.

Wooten and Hammond (2002) proposed that optical mechanisms separate from
chromatic aberration may hypothetically improve visual performance under the
type of conditions where most yellow filters show enhancement. The authors
termed this improvement the Visibility Hypothesis of macular pigment proposing
the idea that macular pigment may improve vision by reducing the forward
scatter caused by short wavelength dominant light and reducing veiling
luminance through selective absorption. Thibos et al. (1991) determined that the
influences from chromatic aberration on the SMTF were relatively small,
estimated at approximately 0.15D of defocus. Effects of chromatic aberration are
most likely encountered at the upper resolution limits of visual acuity although the
luminous efficiency curve predicts that wavelengths near the edges of the V(λ)
curve will have less effect on human visual sensitivity (Thibos et al., 1991).
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B. Temporal
Neural transmission efficiency within the visual system, like other neural
structures, is limited by a number of conditions including processing speed and
conduction rate (Vaney et al., 1998). A review by Hammond (2005) outlined a
method of determining variations the speed of temporal processing by calculating
the temporal modulation transfer function (TMTF). Spatial visual function can be
described by the contrast sensitivity function, or SMTF, (sensitivity versus spatial
frequency) just as temporal vision can be described by the TMTF (sensitivity
versus temporal frequency) (Regan, 1982). Several studies have explored the
high frequency portion of the TMTF (Rovamo et al., 1984, Mayer et al. 1988 and
Hammond et al., 2005). One of the methods available involves a counter-phased
square wave and is known as the critical flicker fusion (CFF) threshold. Mayer et
al. (1988) found significant differences in the TMTF thresholds related to age
supporting a decline in temporal sensitivity with increasing age. Hammond et al.
(2005) found a positive relationship between MP and CFF and identified that this
association was independent of age. The authors suggested that L and Z could
theoretically improve neural signaling efficiency throughout the visual system.
Renzi and Hammond (2010) measured a comprehensive temporal contrast
sensitivity function (TCSF) using a 1o circular stimulus at the fovea and a 7o
parafoveal location. MPOD was measured using HFP and a 1 o circular stimulus
and found a significant relationship between MP and the full TCSF at the foveal
location (p<0.01) but not the parafoveal location (p=0.07). Their results also
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identified a significant, positive correlation between foveal MPOD and foveal CFF
(r = 0.21, p<0.001).

Renzi et al. (2010) summarize results from a number of sources including Curran
et al. (1990) and Parrot (2008) which indicate that CFF is likely determined postreceptorally and CNS function has a direct influence on CFF thresholds. Hawken
et al. (1996) reviewed the temporal response characteristics between LGN
neurons, which receive direct input from the retinal ganglion cells, and V1
neurons. Their work showed V1 response characteristics with reduced sensitivity
to CFF rates indicating a possible loss of temporal information within the LGN.
Hawken et al. concluded that intracortical mechanisms likely influence V1
temporal response dynamics because their temporal properties are not derived
from the LGN and significant variability in temporal tuning exists. As described
above in the Neural Hypothesis, L and Z have been shown to improve gap
junction transmission efficiency and improvements in signal transduction velocity
(Stahl et al., 2002) both of which may improve temporal processing speed within
the visual system.

C. Differences across the Visual Field
Robson and Graham (1979) described a probability summation hypothesis which
involved 2 underlying assumptions: a target will be detected by a subject when
any one receptive field is activated by the target within the visual field and that
receptive field activation is independent of the likelihood that any other receptive
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field will also be activated. They further hypothesized that the relationship
between contrast sensitivity and spatial frequency can be explained by the
probability summation across the stimulated area if variation in sensitivity across
the visual field is accounted for.

Virsu and Rovamo (1979) described the effects of target area and spatial
frequency on contrast sensitivity depends on a central integrator which sums the
activity of a receptive field over large cortical areas. They determined that CS
may be a result of extensive summation across a number of spatial frequency
channels that have differing levels of sensitivity and specificity. Further, targets
presented at different positions across the visual field will have equal sensitivity
responses if they share equivalent cortical projections: contrast sensitivity is
direct function of the number of stimulated receptive fields.

Pointer et al. (1989) measured differences in contrast sensitivity along each of
the four principle meridians using horizontal grating targets. They determined that
contrast sensitivity is highest for all spatial targets of 0.5-24cpd and parafoveal
reduction in sensitivity can be conveyed as a linear function is contrast sensitivity
is expressed in relative units such as periods of the target.

Previous psychophysical studies have explored the theoretical link between
visual performance and underlying retinal ganglion cell density (Thibos et al.,
1987, Anderson et al., 1991 and Thibos et al., 1996). Thibos et al. (1987)
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provided findings that grating resolution in the peripheral retina is defined by the
ganglion cell density. The authors referred to the underlying neural performance
limitation as sample-limiting performance and further defined the resolution limit
and its relation to aliasing. Further work by Anderson et al. (1991) concluded
that for achromatic targets, peripheral spatial resolution is limited by both an
underlying ganglion cell density and a post-receptoral mechanism.

Thibos et al. (1996) provided a brief review of two separate measures of visual
performance across the visual field described as resolution thresholds and
detection thresholds. Resolution thresholds are referred to as the highest spatial
frequency at which orientation can be recognized and signifies the spacing of the
retinal ganglion cells and the resulting Nyquist limit. Detection threshold is the
highest spatial frequency at which contrast can be recognized and is determined
primarily by the optics of the eye. Thibos et al. (1996) reported that the shape of
the SMTF, or contrast sensitivity function, can be determined by whether a
resolution threshold or detection threshold was used offering further support that
resolution thresholds are restricted by the underlying retinal density of the
ganglion cell receptive fields.

D. Interaction of Visual Performance Measures
A decrease in visual performance may be caused by the loss of retinal image
contrast due to surface reflections or bright luminance sources creating
increased forward scatter of light within the eye (De Waard et al., 1992).
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Intraocular scatter has an inverse relationship to the glare angle squared. Vos
(1984) suggested that visual effects experienced in disability glare, as defined by
the CIE, are similar to visual effects experienced in intraocular scatter. The
resulting disability glare can decrease visual performance by two primary means,
direct reduction in the contrast of the retinal image and a veiling luminance at the
retinal plane caused by peripheral intraocular scattering. According to a review
by Vos (2003), at smaller angles of incidence, inhibitory neural interactions at the
retinal level can add to disability glare.

Franssen et al. (2006) discussed intraocular scatter as a measure of the effects
caused by the inhomogeneities of the eye’s optical elements on incident light
arriving at the cornea. Backward light scatter will primarily reduce the amount of
light reaching the retina while forward scatter will reduce contrast (both chromatic
and achromatic) at the retina by increasing the spread of light. This forward
scattering may cause a veiling luminance across the retina leading to a decline of
resulting image contrast (van den Berg, 1995). Puell et al. (2008) found that intersubject differences in foveal MPOD showed a significant correlation with
intraocular scatter in healthy, non-cataractous eyes. It has been identified by both
Stringham et al. (2011) and Hammond et al. (2012) that MPOD has a positive
effect on disability glare which suggests that MPOD may also have a role in the
reduction of intraocular straylight.
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Reading and Weale (1974) first introduced the role of MP on longitudinal
chromatic aberration and Thibos (1987) found that, in reference to lateral
chromatic aberration, selective filtering by MP increased target contrast by a level
that increases with spatial frequency to a factor of ~1.5 at the spatial resolution
limit. Hemenger (1992) introduced the proposed role the MP’s preferential
absorption of plane polarized light may be related to lower root-mean-square
aberrations. The dichroic nature of MP (Bone et al., 1992), with its major axis of
absorption oriented tangential to a circle centered on the fovea support a
potential absorption property of plane polarized light.

III. Existing Evidence of Macular Pigment Role in Visual Performance
One of the first experiments to evaluate the association between MPOD and
visual performance under glare conditions was published by Stringham and
Hammond (2007). Thirty-six (36) subjects (age range: 18 to 41), using HFP with
a free-view macular densitometer, developed individual spatial distribution
profiles of MPOD. Photostress recovery times and grating target visibility under
glare conditions were measured in a Maxwellian-view optical system. For glare
disability assessments, subjects fixated a 1° target utilizing a 100% contrast
grating target. The radiometric power of an annulus (which served as the glare
source) with an 11°/12° inner/outer diameter was adjusted until the grating target
was no longer visible. Thresholds under glare conditions revealed significant
correlation coefficients related to MPOD (p< 0.001) when using a broadband
xenon light source. The authors concluded that an increase in MPOD is related
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to decreases in glare disability and photostress recovery times consistent with
known established spectral absorption characteristics and spatial distribution
profile of MPOD.

The Stringham and Hammond investigation (2008) assessed the relationship of
MP to improvements in glare disability and photostress recovery time after
supplementation with lutein and zeaxanthin for 6 months. Forty (40) subjects
(mean age 23.9) were evaluated by HFP to create spatial MPOD profiles at
baseline, 1, 2, 4, and 6 months. Both disability glare and photostress recovery
were assessed with a Maxwellian-view optical system. For assessments of
disability glare, a 100% contrast, 1°grating stimulus of 5cpd was used and the
intensity of an 11 °inner/12 °outer annular xenon-white source was adjusted until
the grating stimulus could no longer be resolved. Photostress recovery employed
the same target using a 5o central disc delivering 5.5 log Trolands of retinal
illuminance for a 5 second duration. At baseline, visual performance as assessed
by glare disability and photostress recovery showed high correlation with MPOD.
After 6 months of L and Z supplementation, mean central MPOD increased
nearly 40% and glare disability (r = 0.59, p < 0.0001) and photostress recovery ( r
= -0.66, p < 0.0001) were found to be significantly related to increases in MPOD.

Loughman et al. (2010) evaluated the association between MPOD and visual
performance. One hundred forty-two (142) subjects (mean age: 41 with SD of +/6) were assessed to determine the spatial profile of their MPOD through HFP.
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Visual performance measurements included best corrected visual acuity, contrast
sensitivity, glare disability, and photostress recovery time. Glare disability was
measured under medium and high glare conditions assessed at 42 lux and 84
lux, respectively. Psychophysical measurements of best corrected visual acuity
and central contrast sensitivity showed a positive correlation (p < 0.05) with
MPOD. Photostress recovery time and glare disability showed no significant
correlation to MPOD (p>0.05). Important to note, the glare source output utilized
by Loughman et al. did not contain a significant amount of SW light. The source
utilized for the glare disability and photostress recovery were tungsten-based
sources. These sources provide substantially more spectral irradiance between
520-750nm than between 410-520nm where the spectral absorbance of MP is
greatest.

Nolan et al. (2011) evaluated the augmentation effects of macular pigment (MP)
and potential resulting enhancement of visual performance measured by best
corrected visual acuity, contrast sensitivity, glare disability, photostress recovery
time, and subjective questionnaire related to visual function. One hundred
twenty-one (121) subjects were randomly divided into active (12mg L and 1mg Z
oral supplement) and non-active (placebo oral supplement) group. Subjects were
evaluated at baseline, 3, 6, and 12 months through HFP determination of their
MPOD spatial profile and psychophysical measurements of visual performance.
At 12 months, a statistically significant rise in MPOD was measured in the active
group but this increase in MPOD was not linked with a corresponding
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improvement in visual performance measures. Nolan et al. (2011) did report
statistically significant differences in mesopic contrast sensitivity at high spatial
frequencies and in mesopic contrast sensitivity at low spatial frequencies under
high glare conditions. Important to note, the glare source output utilized by Nolan
et al. was identical to the 2010 Loughman et al. study. The spectral output of the
tungsten-based source created markedly greater LW visible light (520-750nm)
than SW visible light (410-520nm). The lack of a SW light component within the
glare source accompanied by the absence a significant correlation between
MPOD and both glare disability and photostress recovery may offer further
support of the wavelength dependence of MP-related improvements on visual
function.

Stringham et al. (2011) evaluated 3 types of visual performance under glare
conditions: photostress recovery time, disability glare, and discomfort glare.
Twenty-six (26) subjects were measured to determine the spatial profile of their
MPOD through HFP. Visual performance measurements for the photostress
recovery and glare disability were determined through correct orientation
identification of a Gabor patch. Discomfort glare was assessed during glare
testing with a visual discomfort scale. Glare was produced using high intensity
white LEDs. MP was shown to be significantly (p<0.05) associated with all 3
measures of visual performance. Importantly, this study utilized natural viewing
that involved the effects of pupil diameter allowing a greater generalization to
typical, environmental viewing.
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Hammond et al. (2012) performed the first direct test of the Visibility Hypothesis
originally proposed by Wooten and Hammond (2002). Five (5) young, healthy
subjects experienced with psychophysical testing procedures were evaluated.
MPOD was assessed with HFP and visibility was evaluated by measuring
contrast sensitivity at 8cpd using a xenon source optical system which created a
sine wave grating target. Natural sunlight and atmospheric haze was simulated
using a broad-spectrum filter and alterations to MPOD were replicated by a
variable path length filter that represented the absorption spectrum of MP.
Results showed that a simulated increase in MPOD of 0.25 density units lowered
the average contrast sensitivity threshold approximately 25% and an additional
0.25 density units lowered the threshold an additional 10% with an effect plateau
at 0.50 density units. Their results suggested that the greatest improvements in
CS are associated with modest increases in MPOD.

A 2013 study by Hammond et al. investigated the relationship of serum lutein and
zeaxanthin with MPOD, glare disability, photostress recovery, and chromatic
contrast. One hundred fifty (150) healthy subjects were assessed using cHFP to
measure MPOD and a Maxwellian-view broadband light source to measure
visual performance. Glare disability was evaluated by increasing the radiometric
power of an annulus until it caused a loss of resolution for a 4cpd grating central
target. Photostress recovery was recorded as the time elapsed before the subject
was able to recognize a foveal target following a 5 second exposure to a glare
source. Chromatic contrast was measured as the intensity of a 460nm
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background which resulted in a loss of visibility of a 4cpd grating central target
with a wavelength of 600nm. Their results showed a significant relationship
between MPOD and glare disability (r = 0.24, p < 0.01), photostress recovery (r =
0.18, p = 0.01) and chromatic contrast sensitivity (r = 0.46, p < 0.001). MPOD
was also found to be significantly related to combined serum L/Z (r = 0.31, p <
0.01).

To date, a majority of previous studies have focused on the establishment of
central visual function with foveal MPOD measurement. A number of
investigations have demonstrated the distribution profile of MP within the sensory
retina (Loughman et al., 2010 and Nolan et al., 2011 and Stringham et al., 2011)
and all used measures of central visual performance. Where the deficits can be
found in the literature is in defining the role of parafoveal MPOD and its relation
to visual performance. Also important is the relationship between visual
performance and foveal MPOD versus integrated MPOD. Robson et al. (2003)
and Trieschmann et al. (2006) reported that foveal measures of MPOD show low
correlations with total amount of MPOD measure across the spatial distribution.
Wenzel et al. (2006) also hypothesized that an integrated measure of MPOD is
potentially more important than a measure at a single eccentricity. This
underscores the importance of determining the complete spatial distribution
profile of MPOD: Certain spatial distributions may show significantly different
foveal versus parafoveal measurements and quantification of foveal MPOD
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levels in isolation may poorly reflect the potential role of MP in visual
performance.

IV. Hypotheses
Previous studies have examined the relationship between foveal MPOD
measurements with central visual function thus ignoring the spatial distribution.
The previously identified relationship between MPOD and the 3 components of
the Optical Hypothesis in the foveal region supports the investigation of
parafoveal relationships with MPOD. My hypotheses include:
1)

MPOD has an inverse relationship with glare disability and contrast
sensitivity at foveal and parafoveal retinal loci.

2)

Integrated measures of MPOD across the diameter of the stimulus will
better predict visual performance compared to discrete point
measurements

3)

Integrated MPOD is inversely related to intraocular scatter

V. Methods
The current study included a total of 33 subjects. The n-value was derived from
an a priori power analysis using an 80% power estimate and a Cohen’s effect
size of 0.5 expressed by the equation: N = (2.8/0.5)2 + 1 (Howell, 2007). The total
subject sample number was divided into three equal cohorts of 11 subjects. Each
cohort performed all testing over a 12 week period to ensure each subject was
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able to complete all testing within a single academic semester and that all
subjects progressed through the testing at the same rate.

Study inclusion criteria required no evidence of ocular pathology and best
corrected visual acuity of 20/25 in the right eye and age less than 35 in order to
avoid any presbyopic effects. Volunteer subjects were recruited from current
optometry students enrolled at UMSL College of Optometry. All subjects were
current optometry students familiar with the devices and techniques presented
during testing. The study sample included 11 males and 22 females with a mean
age of 24.2 years ( = 2.7). All procedures were approved by the UMSL
Institutional Review Board.

MPOD Spatial Distribution Measurements
The study utilized a novel device based on Wooten et al. (1999) (Figure xx) that
used customized heterochromatic flicker photometry (cHFP) to measure the
nasal, temporal, superior, and inferior MPOD at 0o, 2o, 4o, 6o and 80 eccentricity.
This radial pattern was used to generate a spatial profile of an individual subject’s
MPOD that was then compared to a spatial distribution of contrast sensitivity and
glare sensitivity at the corresponding degrees of eccentricity.
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Figure 2
A diagram of the free-view optical system used to measure MPOD. (A1 and A2) Apertures 1 and 2; (BS) beam splitter;
(L1 and L2) convex achromatic lenses; (PC) photocell; (S1 and S2) LED sources; (D1 and D2) optical diffusers (Wooten
et al., 1999)

The cHFP device is a free-view device requiring no head stabilization (Fig xx)
with a fixed 40cm distance consisting of a 10o background field generated by a
LED (472nm peak) and a holographic diffuser (85% transmission with 20 o
viewing angle) measuring 2.75 cd/m2. A 1o stimulus is superimposed on the
background field using a beamsplitter and a triad LED arrangement consisting of
two 460nm and one 564nm LED (half-bandwidth of 10nm). The measured peak
output of the superimposed stimulus was 5.20cd/m 2 for the 564nm LED and
21.2cd/m2 for the 460nm LEDs. The LED triad utilized a pulse-width modulation
(PWM) frequency control. PWM was chosen to regulate frequency which allows
use of contact current control of the LED input. Constant current LED input
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allowed strict control of spectral output. The triad array created a peak
wavelength of 460nm and 564nm LEDs to flicker in counterphase to one another
and an inverse yoked luminance control set at 0.10 cd/m 2 for each detent of the
subject control knob. A 5 arcmin fixation dot was printed on a transparent thin
film and controlled by a step-motor which allowed precise positioning at
eccentricities relative to the center of the 1o stimulus target.

Figure 3
The cHFP device designed and built for use during this project used to measure MPOD along 8 meridians at 0o, 2o, 4o and
6o eccentricities.

Each MPOD assessment session lasted for approximately 45-50 minutes but
never exceeded 1 hour to control for fatigue and compliance. Three sessions
were scheduled for each subject and a fourth was optional if the subject required
additional familiarization with the technique to reach repeatability during the initial
training. Each session used 5 repeated measures of their individual critical
flicker fusion (CFF) threshold before any assessment of their MPOD was
performed.
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In order to optimize the accuracy of the MPOD measurements, each subject was
required to identify their central CFF that determined all stimulus flicker rates at
each retinal location. To begin each trial, the subject was adapted in a dark room
for 5 minutes prior to beginning the testing. The subject then placed an eye patch
over their left eye and chin in the fixed chin rest. A 40cm distance check was
performed to ensure proper alignment and distance. Subjects were instructed to
maintain stable head posture during testing and to close and cover their patched
left eye. Once the device and subject were comfortably aligned, the subject
would then grasp the adjustment knob prior to flicker threshold testing. The CFF
was determined by isolating the 564nm LED as the flickering stimulus
superimposed on the 472nm background. The stimulus frequency was set at
values well below expected CFF thresholds and the subject was asked about the
perception of flicker. If no flicker was perceived, the frequency of the 564nm
stimulus was decreased until a prominent flicker was achieved. If prominent
flicker was recognized by the subject, they were then instructed to turn the
adjustment dial to the right 1 click at a time at a rate approximate to 1-2 seconds
per click. The subject was asked to maintain strict fixation on the black dot in the
center of the stimulus and assess the entire stimulus for flicker. The subjects
were instructed to blink enough to allow for comfort but to assess for presence of
flicker only when holding eye open without blinking. When the subject reached a
point that a null flicker was reported, they were asked to stop, blink several times,
and refixate the stimulus center. If null flicker was still reported, the frequency
value was recorded and the examiner reset the flicker frequency to a value well
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below threshold. If minimal flicker was still perceived by the subject, they were
instructed to add only 1 additional click to the right to eliminate the flicker. If null
flicker was achieved, this flicker frequency was recorded. If minimal flicker was
still reported, the flicker value was reset and the CFF procedure was performed
from the beginning. Five consecutive measures were taken and all values were
within 1 Hz of one another or the testing was stopped, the subject was allowed to
rest, and the CFF procedure was started from the beginning. A mean value of the
5 repeated CFF measures were used to calculate the customized central flicker
rate for each subject. Consistent with Snodderly et al. (2004) and Hammond et
al. (2005) and Stringham et al. (2008), the subject’s central CFF was applied to
an algorithm lookup table within the device programming to determine the fixed
stimulus flicker rate at foveal, 2o, 4o, 60 and 8o eccentricities.

Once the repeated measure CFF had been determined, the device was set to
“LOCK” which then allowed the stimulus target to display the counter-phased
460nm/564nm stimulus. Foveal measurements of MPOD was assessed by
maintaining the black fixation dot at the stimulus center and the examiner set the
displayed relative units of the 460nm LED to values well-below equiluminance
thresholds. The subject was then asked to assess the entire 1 o stimulus for
flicker. If flicker was perceived, the 460nm luminance was decreased by the
examiner and the subject was reassessed. If flicker was still perceptible by the
subject, the CFF testing was repeated to maximize subject familiarity with flicker
perception and improve the accuracy of the subject’s central CFF. If null flicker
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was perceived, the subject was instructed to turn the adjustment dial to the right
1 click at a time at a rate approximate to 1-2 seconds per click. The subject was
asked to maintain strict fixation on the black dot in the center of the stimulus and
assess the entire stimulus for flicker. The subjects were instructed to blink
enough to allow for comfort but to assess for presence of flicker only when
holding eye open without blinking and follow a method of limits paradigm
identical to the described CFF threshold measurement.

Each session included five 0o and 80 eccentricity measurement values. The first
session assessed the 2o eccentricity, the second session assessed the 4o
eccentricity, and the third session included the 6o eccentricity. These
eccentricities were assessed using the same procedure as the foveal
measurement with the exception of the point of fixation. The examiner set the
fixation dot to the corresponding eccentricity relative to the stimulus center. Each
subject began with a different meridian to control for order effects. For example,
Subject 1 began with temporal measurements, Subject 2 began with superior
measurements, Subject 3 began with nasal measurements, and Subject 4 began
with inferior measurements. This pattern was followed for all subjects in the same
eccentricity. During the second session for all subjects, each began with a
different meridian than assigned during their first session (i.e. Subject 1: begins
with Session #1 at temporal location, Session #2 at superior location, and
Session #3 at nasal location). Subjects were instructed to occasionally move
their eyes to the midpoint of black fixation dot and stimulus and then immediately
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back to fixation to overcome stimulus fading effects. The subjects were also
instructed to blink several times and refixate the black dot before assess
presence of stimulus target flicker. When parafoveal stimulus flicker was first
perceived, the subjects followed the same protocol for determining foveal flicker:
When the subject reached a point that a first, perceptible flicker was reported,
they were asked to stop, blink several times, and refixate the stimulus center. If
no perceptible flicker was reported after the refixation, the subject was instructed
to continue with the testing. If perceptible flicker was still reported after refixation,
the subject was asked to add only 1 additional click to the right. If the subject
reported more pronounced flicker, the examiner would record the 460nm
radiance value was recorded. If no additional flicker prominence was still
perceived by the subject, they were instructed to remove the extra click by
turning the adjustment dial to the left. This technique was performed for 5
repeated measurements and a mean value was recorded for the foveal 460nm
radiance value.

The cHFP device was used to create the spatial map of MPOD for each subject
by assessing optical density of the macular pigment using a 1o stimulus at 2o, 4o,
6o eccentricity along four principle meridians: horizontal (0o / 180o) and vertical
(90o / 270o) resulting in 13 discrete values (Figure 4). These values were
recorded to produce a spatial map of MPOD.
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Figure 4
Example of a radial pattern depicting the 8 principle meridians. MPOD was measured at 0°, 2°, 4°, and 6° locations along
the inferior, nasal and temporal meridians. Contrast sensitivity was determined at 3, 6, and 9cpd at the corresponding
retinal locations.

Two methods of calculating the MPOD spatial distribution across the macula for
each subject were employed. The first method calculated the kurtosis values for
each spatial distribution. Kurtosis an indicator of normality and measures the
peak of the distribution. The greater the kurtosis value the more peaked the
distribution relative to a normal distribution and is typically referred to as
leptokurtic. The lesser the kurtosis value the flatter the distribution relative to a
normal distribution and is typically referred to as platykutic. The second method
calculated the area under the curve (AUC) value. MPOD values from each
measured loci were plotted using Cartesian coordinates on an x,y graph.
OriginPro9 software (OriginPro Corp, Northampton, MA) was utilized to best-fit
the spatial distribution across the entire 16o macula and calculate integrated
values for the 1o stimulus diameter at each loci and the 16o distribution.
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Contrast Sensitivity and Glare Disability Measurements
Stimuli for the CS and GD stimuli were generated with the Psykinematics
program (Kybervision, Montreal, Canada) to create a vertical sinusoidal spatial
grating pattern with a Gaussian envelope as a stimulus. These stimuli were
presented on a 19”-CRT monitor using gamma correction of existing nonlinearity. Display calibration of the CRT monitor was assessed using a Spyder 3
(Datacolor, Lawrenceville, NJ) device recognized and incorporated into the
Psykinematics program. Non-linearity was measured regularly throughout the
project. The range of gamma reported by the Spyder3 device was 1.91 to
1.98.The stimuli were presented on a background with a luminance controlled at
20cd/m2. The psychophysical technique method of limits with an adaptive
staircase (described below) was utilized to determine sensitivity threshold values.
A mean value calculated from 6 reversals was recorded as a contrast sensitivity
threshold estimation. The vertical sinusoidal spatial grating pattern was displayed
with a 200 millisecond duration in order to control for fixation loss during stimulus
presentation.

The Michelson contrast value for each retinal location began at suprathreshold
levels (as determined from 10 subject pilot study) and decreased in a relative
step size at 15% before 1st reversal and increase in a relative step size at 15%
until second reversal. This relative change in contrast continued until 6 reversals
were recorded and the mean of the 6 reversals was recorded as the threshold
contrast sensitivity threshold.
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Contrast sensitivity functions utilized luminance modulated sinusoidal gratings
with a vertical orientation. The stimulus subtended a visual angle of 1o with a
spatial Gaussian envelope. Measurements were taken under mesopic (3cd/m2)
conditions using a method of limits described above with respect to a central
fixation cross. Values were recorded for 3 spatial frequencies (3 / 6 / 9cpd) at
each eccentric point along the above listed meridians.

GD was determined as the difference in contrast sensitivity between glare
conditions and no glare conditions (CSNo Glare – CSGlare) at each retinal loci. Glare
condition measurements were also taken at 2o, 4o, 6o of eccentricity along each
of the above listed principle meridians. The glare apparatus utilized two 5o glare
sources produced by two achromatic LEDs (Luxeon model LXHL LW6C, Luxeon
Corp., Randoph, VT) located in 1” diameter optical tubes. Each LED is attached
to the base of a 6” tube in conjunction with 3 other optical system elements: 1) a
10o holographic diffuser (used to make the glare image uniform, 2) an adjustable
circular iris (used to define the glare circle size of 5o), and 3) a convex lens (used
to focus the glare source at the distance of the CRT monitor). The two tubes
were positioned below the subject’s line of sight, directed vertically and reflected
from a beam splitter oriented at 45o into the subject’s line of sight. Based on the
optical system, each glare source created a luminance of 1500 cd/m2 with a
color temperature of 6500K. Measurement of the glare sources was taken with a
spectrophotometer (model 650; Photo Research Inc., Chatsworth, CA). Strict
control of the luminance output was achieved using software-controlled PWM
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and luminance output was well within accepted safety values not to produce
visible light-induced ocular damage.

Figure 5
The novel glare device designed and built for use during this project used to produce flanking glare sources to surround
the 1o grating stimulus at each retinal loci along the four cardinal meridians at 0o, 2o, 4o and 6o eccentricities.

The two glare sources were aligned horizontally and each was centered 5o from
the midpoint of the 1o sinusoidal grating pattern. The inner boundaries of the
glare source and the center of the grating pattern are separated by 3o of visual
angle. The subject’s view of the glare source is two circles of light spaced
laterally (inner edge to inner edge) by 5o of visual angle. Infra-red camera focus
and subject feedback were employed through a precise alignment protocol
ensuring that the glare circles were accurately positioned the correct distance
from the midpoint of the grating pattern. Subjects were presented the same
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stimuli as used during the contrast sensitivity function testing described above.
Subjects viewed the grating targets through a beam splitter that reflected the
superimposed glare sources on the CRT background.

Subjects were adapted at mesopic (<3cd/m2) conditions for 5 minutes preceding
each session. Five (5) measurements were conducted in total in order to
maximize validity and repeatability. Sequential presentation of the stimuli for
each subject was uniquely determined by a random sequence generator to
control for order effects. Single sessions included: 1) foveal threshold
determinations for all 3 spatial frequencies and 2) All eccentricity measurements
at each meridian (0o, 90o, 180o, 270o) for each spatial frequency. Each session
was performed under no glare and glare conditions. This resulted in a total of 8
contrast sensitivity threshold sessions for each subject. Initial starting spatial
frequency was randomized to control for order effects. CS threshold under no
glare conditions was always performed first to allow familiarization of the task
and, when possible, no more than 1 day would elapse between no glare and
glare conditions.

An infrared camera was used to monitor the eye during stimulus presentation to
ensure proper fixation within 0.5o or less. A transparency overlay with concentric
rings corresponding to 0.5o of visual angle was applied to the video monitor.
Subjects were encouraged throughout to blink frequently to minimize the Troxler
effect and to regain fixation on central cross before button response to ensure
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proper alignment of eye prior to stimulus presentation. Optional breaks were
given at subjects request and mandatory breaks of 5 minutes were given at the
completion of each eccentricity. Typical duration of contrast sensitivity testing
was approximately 45 to 50 minutes per session.

MPOD was measured at four eccentricities (0o, 2o, 4o and 6o) and resulting
values at each retinal eccentricity are a mean of five consecutive trials. With the
exception of the foveal measurements, the MPOD at the remaining three retinal
eccentricities were calculated as a mean of five consecutive superior inferior,
nasal and temporal measurements at that eccentricity for a total of 20
measurements per mean eccentricity value.

MPOD mean values for each retinal loci (0o, 2o, 4o and 6o) were fit to a
Lorentzian distribution for both stimulus center and stimulus point of highest
retinal sensitivity using OriginPro9 software (Figure 6). For the resulting two
distributions, MPOD values at each retinal loci were determined by three
separate methods: 1) Stimulus discrete value, 2) stimulus integrated across 1o and
3)

area under the curve (AUC) calculations integrated across 16o. Each

distribution would have 4 discrete MPOD values and 5 integrated MPOD values
from -0.5o to 0.5o, 1.5o to 2.5o, 3.5o to 4.5o, 5.5o to 6.5o and -8o to 8o. Peak foveal
measures of MPOD will have only a single discrete measure due to the shared
retinal point of stimulus center and stimulus point of highest retinal sensitivity.
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Figure 6
Hypothetical spatial distribution of MPOD fit to a Lorentzian function. The grey shaded area represents a 1 0 area from 0.50 to 0.50. Origin Pro9 software was used to calculate integration values of a 10 area at all measured eccentricities
including the area under the curve from -80 to 80.

Contrast Sensitivity, Glare Disability and Relative Glare Disability Correlations
with MPOD
CS differences between horizontal and vertical meridians were expected and
well-documented (Westheimer, 1982 and Pointer et al., 1989). Therefore,
correlations between CS and calculated MPOD for 0o, 2o, 4o and 6o eccentricities
were evaluated as separate analyses: a horizontal meridian mean CS, a vertical
meridian mean CS and a mean CS including all four meridians. Glare disability
(GD) was measured as a difference in CS between no glare conditions and glare
conditions of the same visual stimuli. Resulting GD values were determined as
absolute GD and relative GD. Absolute GD was calculated as: CSNo Glare –
CSGlare and is referred to as GD. Relative GD was calculated as : (CSNo Glare –
CSGlare) / CSNo Glare and is referred to as RGD.
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Correlations of discrete MPOD values along with the two integrated values
across the 1o stimulus for each Lorentzian distribution with CS, GD and RGD of
the 1o grating target corresponding to the same retinal loci at 3 separate spatial
frequencies: 3cpd, 6cpd and 9cpd were calculated. At all 3 spatial frequencies,
MPOD correlations with GD and RGD were evaluated in two ways. First, existing
literature exploring MPOD and potential effects on CS and GD have utilized
foveal MPOD measurement in their analysis (Hammond et al., 2013 and
Stringham et al., 2011). In an effort to build upon existing research, foveal
measurements of MPOD were correlated with GD and RGD at each eccentricity
(0o, 2o, 4o, and 6o). Second, previous studies exploring MPOD and potential
effects on CS and GD have not evaluated the relationship of parafoveal MPOD
values with parafoveal visual performance. In an effort to expand existing
research, correlations of corresponding eccentricities of MPOD and GD and RGD
were also performed (i.e. 20 MPOD with 20 GD and RGD, 40 MPOD with 4o GD
and RGD and 60 MPOD with 6o GD and RGD). The sample n-value was derived
from an a priori estimate using 80% power and a Cohen’s effect size of 0.5 and
all correlational analyses were designed prior to data collection. Due to the a
prior nature of the experimental design, Bonferroni corrections were not utilized
in an effort to reduce the risk of false negatives and the consequent decrease in
statistical power.

Independent sample t-tests were incorporated to evaluate differences in GD and
RGD between the highest and lowest quartiles of foveal MPOD. A Levene’s
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Tests for Equality of Variances was also performed for each independent sample
t-test. If a significant Levene’s test was identified, the highest and lowest quartiles
of foveal MPOD are assumed to have unequal variances. In such cases, a nonparametric Mann-Whitney test for significance was performed. Effect sizes for
independent t-test results were also calculated.

Scatterplots were also performed across all 3 spatial frequencies and were
evaluated using GD and RGD. First, foveal measurements of MPOD were
correlated with GD at each eccentricity (0o, 2o, 4o, and 6o) as three different
calculations (i.e. 1) foveal discrete value vs. 0o eccentricity, 2) foveal MPOD
integrated across 1o assuming stimulus center vs. 0o eccentricity and 3) foveal
MPOD integrated across 1o assuming stimulus point at highest retinal sensitivity
vs. 0o eccentricity). Second, the same three foveal measurements of MPOD were
plotted against RGD at each eccentricity. Covariance values and regression
relationships between foveal MPOD and GD and RGD for each scatterplot were
evaluated.

Intraocular Scatter Correlations with MPOD
Intraocular forward scatter was assessed through a direct compensation
comparison method using the C-Quant device (Oculus, USA). The C-Quant
device is a commercially-available clinical device able to measure forward
scattered intraocular light through a direct comparison method. The device uses
hemifield comparison of flicker, similar to the flicker perception utilized for the
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cHFP device. The flicker compensation comparison is calculated using a 3.3o
diameter target along with a glare source annulus with an inner diameter of 10 o
and an outer diameter of 20o with a background luminance of 25cd/m2. A 2AFC
method is employed using a fixed temporal rate of 8Hz randomly given to one
side of the hemifield. The subject was instructed to indicate the lateral side of the
target in which flicker is perceived. A complete description of the psychophysical
technique is provided by van den Berg et al. (2011). The validity and reliability
algorithms are incorporated within the C-Quant device and all assessments of
intraocular scatter will follow the established guidelines of the commercial device.
A mean intraocular scatter value was determined using the first 5 valid,
repeatable measures as determined by the commercial device and represented
as ESD (estimated standard deviation) and Q (reliability) parameters.

MPOD influences on intraocular scatter were evaluated by four different values:
foveal stimulus discrete value, foveal stimulus integrated across 1o, AUC
calculations integrated across 16o assuming stimulus center and AUC integrated
across 16o assuming stimulus point of highest sensitivity were evaluated as
Pearson correlation coefficients with measures of intraocular scatter.

Scatterplots were also performed and evaluated in four ways: foveal stimulus
discrete value, foveal stimulus integrated across 1o and AUC calculations
integrated across 16o for each distribution were plotted against the mean
intraocular scatter value for each subject.
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VI. Results
A. Macular Pigment Spatial Distribution
The MPOD spatial distribution results for the 33 subject sample was fit to a 1storder exponential decay curve to assess the variability in the data described by
the r2 value in two different methods:
1) Center point of 1o stimulus at each foveal eccentricity
2) Point of highest sensitivity within the 1o stimulus at each foveal eccentricity
The resulting MPOD values at each foveal eccentricity are a mean of the
superior inferior, nasal and temporal measurements from all 33 subjects.
Resulting MPOD spatial distribution profiles were also fit to a Lorentzian curve
and integrated values across the1o stimulus at each retinal loci and across the
16o of central retina were calculated from both measurements. Individual
Lorentzian distribution curves were also fit for each of the 33 subjects. The cHFP
device identified reliable MPOD spatial distribution maps and showed a 1st order
exponential decay function with eccentricity across the 33 subject study sample.
Standard error of the mean measured for 0o eccentricity was less than 0.01 log
unit, 2o eccentricity was 0.01, 4o eccentricity was 0.01 and 60 eccentricity was
0.02 log unit.

Correlations of MPOD at each eccentricity were performed among the superior,
inferior, temporal, and nasal locations. Correlation values among the four
measured meridians at 2o eccentricity range between 0.955 and 0.968 providing
support of a high level of symmetry among measured meridians when MPOD is
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fit to a 1st order exponential function at each of the measured meridians (Table
1). Correlations among the four measured meridians at 4o eccentricity range
between 0.928 and 0.947 providing additional support of MPOD symmetry
among the measured meridians when the spatial distribution is measured as a 1st
order exponential function at each of the meridians (Table 2). Correlations
among the four measured meridians at 6o eccentricity range between 0.875 and
0.929 supporting the symmetry of MPOD spatial distribution among the four
measured meridians along with increased variability in MPOD assessment with
increasing eccentricity (Table 3). MPOD spatial distribution of the subject sample
fit to stimulus center showed an r2 = 0.885 with a y-intercept of 0.426
corresponding to peak foveal density (Figure 7). The same MPOD values fit to
the stimulus point at highest retinal sensitivity showed an r2 = 0.907 with a yintercept of 0.387 corresponding to peak foveal density (Figure 8).

Figure 7
Graphical depiction of 1st-order exponential decay function demonstrated by MPOD spatial distribution in the 33 subject
sample assuming a stimulus center measurement.
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Figure 8
Graphical depiction of 1st-order exponential decay function demonstrated by MPOD spatial distribution in the 33 subject
sample assuming a highest retinal sensitivity stimuli measurement.

The cHFP device used to assess MPOD was designed with 1o stimuli set to
equal center-to-center stimuli spacing of 2o across the macula. When MPOD
spatial distribution is fit to the center of the stimulus, the 2 o stimulus spacing
remains constant. When the spatial distribution is fit to the inner edge, the foveal
measurement edge lies at 0.5o and the stimulus inner edge at 2o lies at 1.5o of
foveal eccentricity. MPOD spatial distribution was also fit to a 1st order
exponential curve excluding the central measurement value. This approach
allowed a fixed 2o separation for the center of the stimulus fit (e.g. 2o, 4o, 6o) and
the inner edge of the stimulus fit (e.g. 1.5o, 3.5o, 5.5o). The stimuli center fit
(Figure 9) and the stimuli point at highest retinal sensitivity fit (Figure 10)
revealed similar covariance measures of r2 = 0.877 and r2 = 0.876, respectively.
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Figure 9
Graphical depiction of 1st-order exponential decay function demonstrated by MPOD spatial distribution in the subject
sample assuming a stimuli center measurement excluding foveal measurement.

Figure 10
Graphical depiction of 1st-order exponential decay function demonstrated by MPOD spatial distribution in the subject
sample assuming stimulus point at highest retinal sensitivity measurement excluding foveal measurement.

The center stimuli fit exhibited a y-intercept of 0.629 while the inner edge of the
stimuli, analogous to the point of highest retinal sensitivity, fit exhibited a yintercept of 0.474. The inner stimuli edge fit agrees more closely with the peak
foveal density of both the central (y-intercept = 0.426) and point of highest retinal
sensitivity (y-intercept = 0.387) stimuli fit when the foveal measurement value is
included in the 1st order exponential fit.

Results from the kurtosis calculations for the 33 subject sample revealed a mean
value of 2.78 (=1.81). The positive mean value with a relatively large variance
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indicate a leptokurtic distribution that shows a sharp, central peak compared to a
Gaussian distribution and substantial variability in spatial distribution across the
sample. Examples of the variability in kurtosis values are displayed as Lorentzian
curves fit for the subject with the highest kurtosis value (Figure 11) and the
subject with the lowest kurtosis value (Figure 12). The Lorentzian curves for each
subject are fit assuming stimulus center and assuming stimulus point at highest
retinal sensitivity.

Figure 11
Lorentzian fit to stimulus center (left) and stimulus point of highest retinal sensitivity (right) for subject with highest kurtosis
value.

Figure 12
Lorentzian fit to stimulus center (left) and stimulus point of highest retinal sensitivity (right) for subject with highest kurtosis
value.
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AUC calculations showed differences in mean integrated values when spatial
distributions were fit to the center of the stimuli [mean of 1.778 (0.393)] versus
the stimuli position at highest retinal sensitivity [mean of 1.489 (0.331)] (Table 4).
The AUC calculations were highly correlated with one another (r = 0.997,
p<0.001) and showed a non-significant relationship with kurtosis values (AUC
center stimuli r = -0.004, p=0.984 and AUC highest sensitivity stimuli position r =
-0.062, p=0.733).

B. Contrast Sensitivity and Glare Disability across the Macula
Across all three spatial frequency stimuli, a decrease in CS was displayed with
increasing retinal eccentricity. Targets with the lowest spatial frequency (3cpd)
resulted in the highest mean CS at all retinal loci measured and targets with the
highest spatial frequency (9cpd) resulted in the lowest mean CS. Variability
within the 33 subject sample also showed a consistent trend: targets with a
lowest spatial frequency (3cpd) demonstrated the lowest variability and targets
with the highest spatial frequency (9cpd) demonstrated the highest variability.
Variability also increases as a function of retinal eccentricity with the highest
variability at the greatest eccentricity. This relationship was consistent across all
subjects.

CS showed differences along the horizontal meridians as compared to the
vertical meridians. The vertical meridians demonstrated a greater decrease in
CS as a function of eccentricity than the horizontal meridians. The differences in
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CS along the horizontal versus vertical meridians also demonstrated a
dependence on spatial frequency. All three spatial frequencies (3,6,9cpd)
demonstrated a significant difference in measured CS between horizontal and
vertical meridians at 2o, 4o and 6o of eccentricity (Table 4, Table 5 and Table 6).

Independent Samples t-test
o

2 Eccentricity
t-value

Sig.

3cpd stimuli CS

4.761**

<0.001

6cpd stimuli CS

2.617**

0.01

9cpd stimuli CS

2.374*

0.019

Table 5
o

Independent samples t-test for horizontal versus vertical meridians at 2 for 3, 6 and 9cpd grating targets Levene’s Test
for Equal Variances was non-significant so equal variances were assumed (* p ≤ 0.05 and**p ≤ 0.01)

Independent Samples t-test
o

4 Eccentricity
t-value

Sig.

3cpd stimuli CS

5.268**

<0.001

6cpd stimuli CS

3.638**

<0.001

9cpd stimuli CS

3.162**

0.002

Table 6

o

Independent samples t-test for horizontal versus vertical meridians at 4 for 3, 6 and 9cpd grating targets Levene’s Test
for Equal Variances was non-significant so equal variances were assumed (* p ≤ 0.05 and**p ≤ 0.01)

Independent Samples t-test
o

6 Eccentricity

Table 7

t-value

Sig.

3cpd stimuli CS

4.242**

<0.001

6cpd stimuli CS

4.881**

<0.001

9cpd stimuli CS

8.002**

<0.001

o

Independent samples t-test for horizontal versus vertical meridians at 6 for 3, 6 and 9cpd grating targets Levene’s Test
for Equal Variances was significant so equal variances were not assumed (* p ≤ 0.05 and**p ≤ 0.01)
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The highest spatial frequencies (3cpd) showed the least differences in CS
between the horizontal and vertical meridians (Figure 15 and Figure 16) when
compared to the 6cpd targets (Figure 17 and Figure 18) and the 9cpd targets
(Figure 19 and Figure 20). A complete picture of mean CS under no glare
conditions and glare conditions at 0o, 2o, 4o and 6o as a function of eccentricity for
3, 6 and 9cpd stimuli is included in Appendix 2 (Figure 21). The plotted mean
values show a substantial loss of CS with increasing eccentricity using 9cpd
stimuli relative to 3cpd stimuli with greater loss of CS under glare conditions for
9cpd stimuli relative to 3cpd stimuli. Error bars indicate a 95% confidence
interval.

At 3cpd, 21 of 33 subjects showed increased GD with increased foveal
eccentricity. However, 24 of 33 subjects showed increased RGD with increasing
foveal eccentricity. Overall, both GD and RGD were slightly higher at the fovea
where peak MPOD is located relative to GD at 20 where MPOD is measured
lower.

At 6cpd, 24 of 33 subjects showed increased GD with increased foveal
eccentricity. However, 26 of 33 subjects showed increased RGD with increased
foveal eccentricity. Overall, GD was slightly higher at the fovea where peak
MPOD is located relative to GD at 20 where MPOD is measured lower while RGD
tended to be lower at the fovea where peak MPOD is relatively higher.
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At 9cpd, 25 of 33 subjects showed increased GD with increased foveal
eccentricity. However, 28 of 33 subjects showed increased RGD with increased
foveal eccentricity. Overall, GD was slightly higher at the fovea where peak
MPOD is located relative to GD at 20 where MPOD is measured lower while RGD
tended to be lower at the fovea where peak MPOD is relatively higher.

Across all three spatial frequency stimuli, a general trend of increased GD and
RGD with increasing retinal eccentricity was seen, although a number of subjects
showed violations of this trend. More direct relationships between RGD and
eccentricity (i.e. increased RGD with increased eccentricity) were identified than
between GD and eccentricity. Both GD and RGD exhibited a spatial frequency
influence: Higher spatial frequencies showed less inverse relationships.
Increasing retinal eccentricity resulting in increased GD and RGD was identified
more often for 9cpd targets than for 3cpd targets.

GD and RGD also showed less differences along the horizontal meridians versus
the vertical meridians as compared CS. The measured GD and RGD between
the horizontal and vertical meridians showed similar values supporting a
comparable function of MP along all meridians. The effects of MP GD radiate
outward from the fovea where MPOD is the highest to the 6 0 eccentricity where
MPOD greatly reduced.
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C. Relationship between MPOD, Contrast Sensitivity, Glare Disability,
Relative Glare Disability and Intraocular Scatter
MPOD results at each eccentricity were fit to a Lorentzian distribution for both
stimulus center and stimulus point of highest sensitivity. For the resulting two
distributions, MPOD values were determined by three separate methods: 1)
Stimulus discrete value, 2) Stimulus integrated across 1o and 3) AUC calculations
integrated across 16o. Each eccentricity (0o, 2o, 4o, 6o) had three resulting
measures correlated with corresponding eccentricities of CS, GD and RGD.
Foveal MPOD measures were correlated with all measured eccentricities (0o, 2o,
4o, 6o) of CS, GD and RGD. Foveal discrete values, foveal stimulus center
integrated across 10, AUC calculations integrated across 16o assuming stimulus
center and AUC integrated across 16o assuming stimulus point of highest
sensitivity were evaluated as Pearson correlation coefficients with measures of
intraocular scatter.

Independent sample t-testing of differences in CS between the highest and
lowest quartiles of foveal MPOD required ranking of foveal MPOD values. In all
cases, the top and bottom quartiles followed the same ordering when ranked as
foveal MPOD measured as a discrete point, foveal MPOD measured as a 10
integrated area assuming stimulus center measure or foveal MPOD measured as
a 10 integrated area assuming a stimulus point at highest retinal sensitivity.
Therefore, independent samples t-testing will refer to MPOD quartiles as ‘foveal
MPOD’. In general, correlation coefficients of foveal MPOD measured as a 10
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integrated area assuming a stimulus point at highest retinal sensitivity and RGD
tended to show the highest values. Therefore, scatterplot analysis will refer to
foveal MPOD measured as a 10 integrated area assuming a stimulus point at
highest retinal sensitivity as the abscissa value ‘MPOD’ and RGD as the ordinate
value for all figures.

Contrast Sensitivity correlations with MPOD
Overall, no significant correlation between CS and MPOD was demonstrated
within the 33 subject sample. At all 3 spatial frequencies, MPOD associations
with CS were evaluated in 2 ways. First, foveal measurements of MPOD were
correlated with both horizontal meridian CS and vertical meridian CS separately
then as a mean CS incorporating all four meridians at all eccentricities (i.e.
Foveal MPOD vs. foveal CS, foveal MPOD vs. 2o CS, foveal MPOD vs. 4o CS
and foveal MPOD vs. 6o CS). Second, correlations of corresponding
eccentricities of MPOD and both horizontal meridian CS and vertical meridian CS
then as a mean CS incorporating all four meridians were performed (i.e. 2o
MPOD vs. 2o CS, 4o MPOD vs. 4o CS and 6o MPOD vs. 6o CS).

3cpd CS correlations with MPOD
At 3cpd, horizontal meridian CS, vertical meridian CS and mean CS correlations
at all eccentricities (0o, 2o, 4o and 6o) with foveal MPOD measured as a discrete
point, foveal MPOD measured as a 1o integrated area assuming stimulus center
measure and foveal MPOD measured as a 1o integrated area assuming a

P a g e | 106

stimulus point at highest retinal sensitivity were non-significant (Table 8, Table 9,
Table 10).

At 3cpd, 2o horizontal meridian CS, 2o vertical meridian CS and mean 2o CS
correlations with 20 MPOD measured as a discrete point, 2o MPOD measured as
a 10 integrated area assuming stimulus center point measure and 2o MPOD
measured as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity were non-significant (Table 11, Table 12, Table 13). Horizontal
meridian 4o CS, vertical meridian 4o CS and mean 4o CS correlations with all
three measures of MPOD at 4o eccentricity were non-significant (Table 14, Table
15, Table 16). Horizontal meridian 6o CS, vertical meridian 6o CS and mean 6o
CS correlations with all three measures of MPOD at 6o eccentricity were also
non-significant (Table 17, Table 18, Table 19).

An independent sample t-test of CS differences at 0o, 2o, 4o and 6o eccentricities
between the highest and lowest quartiles of foveal MPOD as a 1o integrated area
assuming a stimulus point at highest retinal sensitivity was also performed using
an independent sample t-test. Results for Levene’s Test for Equal Variances
were non-significant so equal variances were assumed. At 3cpd, no significant
differences in CS between top and bottom quartiles of foveal MPOD were
identified (Table 20).
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6cpd CS correlations with MPOD
At 6cpd, horizontal meridian CS, vertical meridian CS and mean CS correlations
at all eccentricities (0o, 2o, 4o and 6o) with foveal MPOD measured as a discrete
point, foveal MPOD measured as a 1o integrated area assuming stimulus center
measure and foveal MPOD measured as a 1o integrated area assuming a
stimulus point at highest retinal sensitivity were non-significant (Table 21, Table
22, Table 23).

At 6cpd, 2o horizontal meridian CS, 2o vertical meridian CS and mean 2o CS
correlations with 20 MPOD measured as a discrete point, 2o MPOD measured as
a 10 integrated area assuming stimulus center point measure and 2o MPOD
measured as a 10 integrated area assuming a stimulus point at highest retinal
sensitivity were non-significant (Table 24, Table 25, Table 26). Horizontal
meridian 4o CS, vertical meridian 4o CS and mean 4o CS correlations with all
three measures of MPOD at 4o eccentricity were non-significant (Table 27, Table
28, Table 29). Horizontal meridian 6o CS, vertical meridian 6o CS and mean 6o
CS correlations with all three measures of MPOD at 6o eccentricity were also
non-significant (Table 30, Table 31, Table 32).

An independent sample t-test of CS differences at 0o, 2o, 4o and 6o eccentricities
between the highest and lowest quartiles of foveal MPOD as a 1o integrated area
assuming a stimulus point at highest retinal sensitivity was also performed using
an independent sample t-test. Results for Levene’s Test for Equal Variances were
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non-significant so equal variances were assumed. At 6cpd, no significant
differences in CS between top and bottom quartiles of foveal MPOD were
identified (Table 33).

9cpd CS correlations with MPOD
At 6cpd, horizontal meridian CS, vertical meridian CS and mean CS correlations
at all eccentricities (0o, 2o, 4o and 6o) with foveal MPOD measured as a discrete
point, foveal MPOD measured as a 1o integrated area assuming stimulus center
measure and foveal MPOD measured as a 1o integrated area assuming a
stimulus point at highest retinal sensitivity were non-significant (Table 34, Table
35, Table 36).

At 9cpd, 2o horizontal meridian CS, 2o vertical meridian CS and mean 2o CS
correlations with 2o MPOD measured as a discrete point, 2o MPOD measured as
a 1o integrated area assuming stimulus center point measure and 2o MPOD
measured as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity were non-significant (Table 37, Table 38, Table 39). Horizontal
meridian 4o CS, vertical meridian 4o CS and mean 4o CS correlations with all
three measures of MPOD at 4o eccentricity were non-significant (Table 40, Table
41, Table 42). Horizontal meridian 6o CS, vertical meridian 6o CS and mean 6o
CS correlations with all three measures of MPOD at 6o eccentricity were also
non-significant (Table 43, Table 44, Table 45).
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An independent sample t-test of CS differences at 0o, 2o, 4o and 6o eccentricities
between the highest and lowest quartiles of foveal MPOD as a 1o integrated area
assuming a stimulus point at highest retinal sensitivity was also performed using
an independent sample t-test. Results for Levene’s Test for Equal Variances were
non-significant so equal variances were assumed. At 9cpd, no significant
differences in CS between top and bottom quartiles of foveal MPOD were
identified (Table 46).

Glare Disability and Relative Glare Disability correlations with MPOD
Non-significant correlations between both horizontal and vertical meridian CS
with MPOD allowed the use of a mean GD value and RGD value incorporating all
four meridians. GD and RGD are measurements of the SW attenuation property
exhibited by MP. This attenuation should be exhibited in the same symmetric
pattern as MPOD spatial distribution indicated by the highly correlated MPOD
values among the four meridians at each eccentricity.

At 3cpd, both foveal GD and RGD correlations with foveal MPOD measured as a
discrete point, foveal MPOD as a 1o integrated area assuming stimulus center
measure and foveal MPOD as a 1o integrated area assuming a stimulus point at
highest retinal sensitivity were non-significant. Two degree GD correlations with
foveal MPOD measured as a discrete point (GD: r = -0.327, p = 0.063), foveal
MPOD as a 1o integrated area assuming stimulus center measure (GD: r = 0.333, p = 0.058) and foveal MPOD as a 1o integrated area assuming a stimulus
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point at highest retinal sensitivity (GD: r = -0.331, p = 0.060) were near
significant. Two degree RGD correlations with foveal MPOD measured as a
discrete point (RGD: r = -0.335, p = 0.058), foveal MPOD as a 1o integrated area
assuming stimulus center measure (RGD: r = -0.342, p = 0.056) and foveal
MPOD as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity (RGD: r = -0.341, p = 0.055) were also near significant. Four degree
GD and RGD correlations with all three foveal MPOD measurements were nonsignificant. Six degree GD and RGD correlations with all three foveal MPOD
measurements were also non-significant (Table 47).

At 3cpd, 2o GD and RGD correlations with 2o MPOD measured as a discrete
point, 2o MPOD measured as a 1o integrated area assuming stimulus center
measure and 2o MPOD measured as a 1o integrated area assuming a stimulus
point at highest retinal sensitivity were non-significant (Table 48). Four degree
GD and RGD correlations with all three measures of MPOD at 4oeccentricity
were non-significant (Table 49). Six degree GD and RGD correlations with all
three measures of MPOD at 6oeccentricity were also non-significant (Table 50).

An independent sample t-test analysis of GD and RGD differences at 0o, 2o, 4o
and 6o eccentricities between the highest and lowest quartiles of foveal MPOD as
a 1o integrated area assuming a stimulus point at highest retinal sensitivity was
also performed. At 3cpd, GD differences at all retinal eccentricities were nonsignificant between top and bottom quartiles of foveal MPOD. However,
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significant RGD differences were identified at 2o, 4o and 6o eccentricity. An effect
size correlation between t-test values and degrees of freedom for GD and RGD
at each eccentricity was also calculated (Table 51).

Independent Samples t-test
3cpd
t-value

Sig.

Effect
Size (r)

-0.522

0.609

0.129

RGD_0

-1.040

0.314

0.252

o

-1.798

0.102

0.410

-2.210*

0.048

0.484

-1.741

0.116

0.399

-2.356*

0.043

0.580

-1.216

0.246

0.291

-2.287*

0.045

0.496

o

GD_0

o

GD_2

o

RGD_2

o

GD_4

o

RGD_4

o

GD_6

o

RGD_6
Table 51

o

o

o

o

Independent samples t-test for glare disability and relative glare disability at 0 , 2 , 4 and 6 for 3cpd grating targets
between the highest and lowest foveal MPOD as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity quartiles. Effect size correlations were calculated using degrees of freedom = 16. Levene’s Test for Equal
Variances was significant so equal variances were not assumed (* p ≤ 0.05 and**p ≤ 0.01)

A Levene’s Test for Equality of Variances between the highest and lowest
quartile were significant at 2o RGD, 4o RGD and 6o RGD. A non-parametric
Mann-Whitney U test between the highest and lowest foveal MPOD quartiles for
o

o

RGD at 4 and 6 resulted in a significant difference at 4o and a non-significant
difference at 6o (Table 52).
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Mann-Whitney U Test
Null Hypothesis of Equal Means
Between Quartiles:

Significance

Decision

0.489

Retain Null Hypothesis

RGD_0

0.436

Retain Null Hypothesis

o

0.113

Retain Null Hypothesis

0.040*

Reject Null Hypothesis

0.136

Retain Null Hypothesis

0.024*

Reject Null Hypothesis

0.387

Retain Null Hypothesis

0.094

Retain Null Hypothesis

o

GD_0

o

GD_2

o

RGD_2

o

GD_4

o

RGD_4

o

GD_6

o

RGD_6
Table 52

o

o

o

A non-parametric independent samples Mann-Whitney U test for glare disability and relative glare disability at 0 , 2 , 4
o

and 6 for 3cpd grating targets between the highest and lowest foveal MPOD as a 1o integrated area assuming a stimulus
point at highest retinal sensitivity quartiles (* p ≤ 0.05 and **p ≤ 0.01)

The range of calculated values for RGD using 3cpd stimuli at each eccentricity
was 0.37 at 0o, 0.36 at 2o, 0.35 at 4o and 0.36 at 6o. The similar range at each
retinal eccentricity indicates no trend of increasing GD with increasing
eccentricity and concurrent decreasing MPOD. Scatterplots of all 3 foveal
measures of MPOD against RGD revealed that in all cases, a positive
relationship was seen at all eccentricities. Scatterplots using RGD and foveal
MPOD measured as a 1o integrated area assuming a stimulus point at highest
retinal sensitivity explained low amounts of variance at all eccentricities (0o r2 =
0.052 [Figure 20], 2o r2 = 0.116 [Figure 21], 4o r2 = 0.069 [Figure 22] and 6o r2 =
0.062 [Figure 23]). Significance for the regression scatterplots was calculated for
foveal MPOD as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity and RGD at 0o, 2o, 4o and 6o for 3cpd stimuli. Non-significant F scores
were found between integrated foveal MPOD and RGD at all eccentricities for
3cpd stimuli (Table 53). A multiple regression using foveal MPOD as a 1o
integrated area assuming a stimulus point at highest retinal sensitivity and
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corresponding kurtosis value as predictors for resulting RGD at all eccentricities
was also performed. Non-significant F scores were identified at all eccentricities
(0o, 2o, 4o and 6o) (Table 54).

Figure 20
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 10 stimuli versus RGD at 00 eccentricity at 3cpd.

Figure 21
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 10 stimuli versus RGD at 20 eccentricity at 3cpd.
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Figure 22
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 40 eccentricity at 3cpd.

Figure 23
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 60 eccentricity at 3cpd.

Although the independent sample t-test revealed significant differences in RGD
between the highest and lowest quartiles of foveal MPOD at 2 o and 4o
eccentricity, scatterplot results demonstrated relatively low amount of variance
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explained at 0o eccentricity (r2 = 0.052) and the 2o eccentricity (r2 = 0.116) and
nearly equivalent covariance measures between 4 o (r2 = 0.069) and 6o (r2 =
0.062) eccentricity.

6cpd Glare Disability and Relative Glare Disability correlations with MPOD
At 6cpd, foveal GD correlations with foveal MPOD measured as a discrete point,
foveal MPOD as a 1o integrated area assuming stimulus center measure and
foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal
sensitivity were all non-significant. However, RGD correlations with foveal MPOD
measured as a discrete point (RGD: r = -0.401, p = 0.023), foveal MPOD
measured as a 1o integrated area assuming stimulus center (RGD: r = -0.412, p
= 0.017) and foveal MPOD measured as a 1o integrated area assuming a
stimulus point at highest retinal sensitivity (RGD: r = -0.418, p = 0.015) were
significant (Table 55).
6cpd

o

o

o

o

o

o

o

o

GD_0 RGD_0 GD_2 RGD_2 GD_4 RGD_4 GD_6 RGD_6

Foveal MPOD
Pearson
-0.240 -0.401* -0.294 -0.355* -0.164 -0.255 -0.044 -0.189
Discrete Point Correlation
Sig. (20.178
tailed)

0.023

0.097

0.041

0.362

0.151

0.807

0.293

Foveal MPOD
Pearson
Integrated
-0.255 -0.412* -0.291 -0.352* -0.159 -0.252 -0.034 -0.180
Correlation
Stimulus Center
Sig. (20.152
tailed)

0.017

0.100

0.044

0.378

0.158

0.850

0.317

Foveal MPOD
Integrated
Pearson
-0.265 -0.418* -0.292 -0.354* -0.155 -0.248 -0.030 -0.173
Stimulus Highest Correlation
Sensitivity
Sig. (20.137
tailed)

0.015

0.099

0.043

.390

0.163

0.870

0.335

Table 55
o

o

o

o

o

Correlation coefficients for MPOD at 0 and glare disability and relative glare disability at 0 , 2 , 4 and 6 for 6cpd grating
targets. (* p ≤ 0.05 and **p ≤ 0.01)
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Two degree GD correlations with foveal MPOD measured as a discrete point,
foveal MPOD measured as a 1o integrated area assuming stimulus center
measure and foveal MPOD measured as a 1o integrated area assuming a
stimulus point at highest retinal sensitivity were non-significant. Two degree RGD
correlations with foveal MPOD measured as a discrete point (RGD: r = -0.355, p=
0.041), foveal MPOD measured as a 1o integrated area assuming stimulus center
measure (RGD: r = -0.352, p = 0.044) and foveal MPOD as a 1o integrated area
assuming a stimulus point at highest retinal sensitivity (RGD: r = -0.354, p =
0.043) were significant. Four degree GD and RGD correlations with all three
foveal MPOD measurements were non-significant. Six degree GD and RGD
correlations with all three foveal MPOD measurements were non-significant
(Table 55).

At 6cpd, 2o GD and RGD correlations with 2o MPOD measured as a discrete
point, 2o MPOD measured as a 1o integrated area assuming stimulus center
measure and 2o MPOD measured as a 1o integrated area assuming a stimulus
point at highest retinal sensitivity were non-significant (Table 56). Four degree
GD and RGD correlations with all three measures of MPOD at 4oeccentricity
were non-significant (Table 57). Six degree GD and RGD correlations with all
three measures of MPOD at 6oeccentricity were also non-significant (Table 58).

An independent sample t-test analysis of GD and RGD differences at 0o, 2o, 4o
and 6o eccentricities between the highest and lowest quartiles of foveal MPOD
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was performed. At 6cpd, non- significant GD differences were identified at 0o, 2o,
4o, and 6o eccentricities between top and bottom quartiles of foveal MPOD.
However, significant RGD differences were identified at 0o, 2o and 4o eccentricity
between top and bottom quartiles of foveal MPOD. An effect size correlation
between t-test values and degrees of freedom for GD and RGD at each
eccentricity was also calculated (Table 59). A Levene’s Test for Equality of
Variances between the highest and lowest quartile was significant at 6o RGD,
however the non-significant t-value required no additional non-parametric testing.
Independent Samples t-test
6cpd

o

GD_0

o

RGD_0

0

GD_2

0

RGD_2
0

GD_4

0

RGD_4
0

GD_6

0

RGD_6
Table 59

t-value

Sig.

Effect
Size (r)

-1.203

0.246

0.288

-2.118*

0.049

0.468

-1.919

0.073

0.433

-2.443*

0.027

0.521

-1.143

0.207

0.274

-2.158*

0.046

0.475

-0.205

0.840

0.051

-1.007

0.329

0.244

o

o

o

o

Independent samples t-test for glare disability and relative glare disability at 0 , 2 , 4 and 6 eccentricity for 6cpd grating
targets between the highest and lowest foveal MPOD as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity quartiles. Effect size correlations were calculated using degrees of freedom = 16. Levene’s Test for Equal
Variances was non-significant so equal variances were assumed. (* p ≤ 0.05 and **p ≤ 0.01)

The range of calculated values for RGD using 6cpd stimuli at each eccentricity
was 0.21 at 0o, 0.34 at 2o, 0.45 at 4o and 0.59 at 6o. The trend of increasing GD
was seen with increasing eccentricity and concurrent decreasing MPOD.
Scatterplots of all three foveal measures of MPOD against RGD revealed that in
all cases, a positive relationship was seen at all eccentricities. Scatterplots using
RGD and foveal MPOD measured as a 1o integrated area assuming a stimulus
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point at highest retinal sensitivity explained the greatest amount of variance at all
eccentricities (0o r2 = 0.175 [Figure 24], 2o r2 = 0.126 [Figure 25], 4o r2 = 0.062
[Figure 26] and 6o r2 = 0.030 [Figure 27]).

Significance for the scatterplots was calculated for foveal MPOD as a 10
integrated area assuming a stimulus point at highest retinal sensitivity and RGD
at 0o, 2o, 4o and 6o for 6cpd stimuli. A significant F value was found between
foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal
sensitivity and 0o and non-significant F values were at 2o, 4o and 6o eccentricities
for 6cpd stimuli (Table 60). A multiple regression using foveal MPOD as a 1o
integrated area assuming a stimulus point at highest retinal sensitivity and
corresponding kurtosis value as predictors for resulting RGD at all eccentricities
was also performed. Non-significant F scores were identified at all eccentricities
(0o, 2o, 4o and 6o) (Table 61).

Figure 24
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 0o eccentricity at 6cpd.
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Figure 25
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 2o eccentricity at 6cpd.

Figure 26
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 4o eccentricity at 6cpd.
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Figure 27
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 6o eccentricity at 6cpd.

Regression Fit for 6cpd Stimuli
Integrated Foveal MPOD

F

Significance

o

6.575*

0.015

o

4.449*

0.043

o

2.039

0.163

o

0.958

0.335

RGD_0
RGD_2
RGD_4
RGD_6

Table 60
Regression fit significance table for foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal
o

o

o

o

sensitivity and relative glare disability at 0 , 2 , 4 and 6 using 6cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01)

As the independent sample t-test revealed significant differences in RGD at 0o, 2o
and 4o of eccentricity between the highest and lowest quartiles of foveal MPOD
as a 1o integrated area assuming stimulus point at highest retinal sensitivity,
scatterplot results demonstrated the greatest amount of variance explained at the
0o (r2 = 0.175) followed by the 2o eccentricity (r2 = 0.1255) and 4o eccentricity (r2
= 0.069) and the least amount of variance explained at the 6 o eccentricity (r2 =
0.030).
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9cpd Glare Disability and Relative Glare Disability correlations with MPOD
At 9cpd, both foveal GD and RGD with foveal MPOD measured as a discrete
point (GD: r = -0.395, p= 0.023 and RGD: r = -0.491, p = 0.004), foveal MPOD
measured as a 1o integrated area assuming stimulus center measure (GD: r = 0.406, p = 0.019 and RGD: r = -0.501, p = 0.003) and foveal MPOD measured as
a 10 integrated area assuming a stimulus point at highest retinal sensitivity (GD: r
= -0.413, p = 0.017 and RGD: r = -0.505, p = 0.003) were significant. Two degree
GD and RGD correlations with foveal MPOD measured as a discrete point (GD: r
= -0.358, p = 0.043 and RGD: r = -0.401, p = 0.017), foveal MPOD measured as
a 1o integrated area assuming stimulus center measure (GD: r = -0.359, p =
0.043 and RGD: r = -0.407, p = 0.016) and foveal MPOD measured as a 1o
integrated area assuming a stimulus point at highest retinal sensitivity (GD: r = 0.377, p = 0.032 and RGD: r = -0.421, p = 0.015) were significant (Table 62).

Four degree GD correlations with all three foveal MPOD measurements were
non-significant. However, four degree RGD correlations with foveal MPOD
measured as a discrete point (RGD: r = -0.372, p = 0.033), foveal MPOD
measured as a 1o integrated area assuming stimulus center measure (RGD: r = 0.368, p = 0.035) and foveal MPOD measured as a 1o integrated area assuming
a stimulus point at highest retinal sensitivity (RGD: r = -0.373, p = 0.033) were
significant. Six degree GD and RGD correlations with all three measures of
foveal MPOD were non-significant (Table 62).
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o

9cpd

GD_0

RGD_0

o

o

GD_2

o

o

o

o

o

RGD_2 GD_4 RGD_4 GD_6 RGD_6

Foveal MPOD Pearson
-0.395* -0.491** -0.358* -0.401* -0.282 -0.372* -0.051 -0.168
Discrete Point Correlation
Sig. (20.023
tailed)

0.004

0.043

0.017

0.112

0.033

0.777

0.351

Foveal MPOD
Pearson
Integrated
-0.406* -0.501** -0.359* -0.407* -0.270 -0.368* -0.044 -0.162
Correlation
Stimulus Center
Sig. (20.019
tailed)

0.003

0.043

0.016

0.128

0.035

0.808

0.368

Foveal MPOD
Integrated
Pearson
Stimulus
-0.413* -0.505** -0.377* -0.421** -0.274 -0.373* -0.043 -0.162
Correlation
Highest
Sensitivity
Sig. (20.017
tailed)

0.003

0.032

0.015

0.123

0.033

0.814

0.367

Table 62
o

Correlation coefficients for foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal sensitivity at 0
o

o

o

and glare disability and relative glare disability at 0o , 2 , 4 and 6 for 9cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01)

At 9cpd, 2o GD and RGD correlations with 2o MPOD measured as a discrete
point (GD: r = -0.421, p = 0.015 and RGD: r = -0.445, p = 0.009), 2o MPOD
measured as a 10 integrated area assuming stimulus center measure (GD: r = 0.434, p = 0.011 and RGD: r = -0.457, p = 0.008) and 2o MPOD measured as a
1o integrated area assuming a stimulus point at highest retinal sensitivity (GD: r =
-0.399, p = 0.021 and RGD: r = -0.411, p = 0.018) were significant (Table 63).
o

9cpd
o

2 MPOD Discrete
Point

Pearson
Correlation
Sig. (2-tailed)

o

GD_2

RGD_2

-0.421*

-0.445**

0.015

0.009

-0.434**

-0.457**

0.011

0.008

-0.399*

-0.411*

0.021

0.018

o

2 MPOD
Integrated
Stimulus Center

Pearson
Correlation
Sig. (2-tailed)

o

2 MPOD
Integrated
Stimulus Highest
Sensitivity

Pearson
Correlation
Sig. (2-tailed)

Table 63
o

o

Correlation coefficients for MPOD at 2 and glare disability and relative glare disability at 2 for 9cpd grating targets. (* p ≤
0.05 and **p ≤ 0.01)
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Four degree GD correlations with 4o MPOD measured as a 1o integrated area
assuming stimulus center measure (GD: r = -0.353, p = 0.044) was significant.
Four degree RGD correlations with 4o MPOD measured as a 1o integrated area
assuming stimulus center measure (RGD: r= -0.381, p = 0.029) and MPOD
measured as a 1o integrated area assuming a stimulus point at highest retinal
sensitivity (RGD: r = -0.359, p = 0.040) were significant (Table 64). Six degree
GD and RGD correlations with all three measures of MPOD at 6o eccentricity
were non-significant (Table 65).
GD_4

o

RGD_4

Pearson
Correlation

-0.332

-0.341

Sig. (2-tailed)

0.059

0.052

-0.353*

-0.381*

Sig. (2-tailed)

0.044

0.029

Pearson
Correlation

-0.339

-0.359*

Sig. (2-tailed)

0.054

0.040

9cpd
o

4 MPOD Discrete
Point

o

o

4 MPOD
Integrated
Stimulus Center

Pearson
Correlation

o

4 MPOD
Integrated
Stimulus Highest
Sensitivity
Table 64

o

o

Correlation coefficients for MPOD at 4 and glare disability and relative glare disability at 4 for 9cpd grating targets. (*p ≤
0.05 and **p ≤ 0.01)

An independent sample t-test analysis of GD and RGD differences at 0o, 2o, 4o
and 6o eccentricities between the highest and lowest quartiles of foveal MPOD as
a 1o integrated area assuming stimulus point at highest retinal sensitivity was
also performed. At 9cpd, significant GD and RGD differences were
demonstrated at 0o and 2o with non-significant differences at 4o and 6oeccentricity
between top and bottom quartiles of foveal MPOD (Table 66).
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Independent Samples t-test
9cpd
t-value

Sig.

Effect
Size (r)

-2.184*

0.049

0.479

RGD_0

-2.867*

0.015

0.583

o

-2.527*

0.022

0.534

RGD_2

-2.811*

0.016

0.575

o

-2.215*

0.042

0.484

-2.452*

0.026

0.523

-0.055

0.957

0.014

-0.808

0.431

0.198

o

GD_0

o

GD_2

o

GD_4

o

RGD_4

o

GD_6

o

RGD_6
Table 66

o

o

o

o

Independent samples t-test for glare disability and relative glare disability at 0 , 2 , 4 and 6 for 9cpd grating targets
between the highest and lowest foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal sensitivity
quartiles. Effect size correlations were calculated using degrees of freedom = 16. Levene’s Test for Equal Variances was
significant so equal variances were not assumed. (* p ≤ 0.05 and **p ≤ 0.01)

Levene’s Test for Equality of Variances between the highest and lowest quartiles
of foveal MPOD as a 1o integrated area assuming stimulus point at highest
retinal sensitivity was significant at 0o RGD, 2o RGD and 4o GD indicating a nonnormal distribution. A non-parametric Mann-Whitney U test between the highest
and lowest foveal MPOD quartiles resulted in a significant difference at both 0o
and 2o RGD and non-significance at 4o GD (Table 67).
Mann-Whitney U test
Null Hypothesis of Equal Means
Between Quartiles:

Significance

Decision

0.031*

Reject Null Hypothesis

RGD_0

0.024*

Reject Null Hypothesis

o

0.019*

Reject Null Hypothesis

0.031*

Reject Null Hypothesis

0.063

Retain Null Hypothesis

0.016*

Reject Null Hypothesis

0.605

Retain Null Hypothesis

0.387

Retain Null Hypothesis

o

GD_0

o

GD_2

o

RGD_2

o

GD_4

o

RGD_4

o

GD_6

o

RGD_6
Table 67

o

o

o

A non-parametric independent samples Mann-Whitney U test for glare disability and relative glare disability at 0 , 2 , 4
o

o

and 6 for 9cpd grating targets between the highest and lowest quartiles of foveal MPOD as a 1 integrated area
assuming stimulus point at highest retinal sensitivity (*p ≤ 0.05 and **p ≤ 0.01)

P a g e | 125

The range of calculated values for RGD using 9cpd stimuli at each eccentricity
was 0.27 at 0o, 0.35 at 2o, 0.43 at 4o and 0.46 at 6o. The trend of increasing GD
was seen with increasing eccentricity and concurrent decreasing MPOD.
Scatterplots of all three foveal measures of MPOD with RGD revealed that in all
cases, a positive regression relationship was seen at all eccentricities.
Scatterplots using RGD explained a moderate to high amount of variance in the
data at 0o, 2o and 4o eccentricities (0o r2 = 0.255 [Figure 28], 2o r2 = 0.177 [Figure
29], 4o r2 = 0.139 [Figure 30]) and a low amount of variance at 6o (r2 = 0.026)
[Figure 31].

Significance for the scatterplots was calculated for foveal MPOD as a 1o
integrated area assuming a stimulus point at highest retinal sensitivity and RGD
at 0o, 2o, 4o and 6o for 6cpd stimuli. A significant F value was found between
foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal
sensitivity and RGD at 0o, 2o and 4o and non-significance at 6o (Table 68). A
multiple regression using foveal MPOD as a 1o integrated area assuming a
stimulus point at highest retinal sensitivity and corresponding kurtosis value as
predictors for resulting RGD at all eccentricities was also performed. Significant F
scores were identified at 0o, 2o and 4o eccentricities with non-significance at 6o
(Table 69).
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Figure 28
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 0o eccentricity at 9cpd.

Figure 29
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 2o eccentricity at 9cpd.
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Figure 30
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 4o eccentricity at 9cpd.

Figure 31
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus RGD at 6o eccentricity at 9cpd.
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Regression Fit for 9cpd Stimuli
Integrated Foveal MPOD

F

Significance

o

10.614 **

0.003

o

6.681 *

0.015

o

5.007 *

0.033

o

0.834

0.369

RGD_0
RGD_2
RGD_4
RGD_6

Table 68
Regression fit significance table for foveal MPOD integrated across 10 assuming stimulus point at highest retinal
o

p

o

o

sensitivity and relative glare disability at 0 , 2 , 4 and 6 using 9cpd grating targets. (*p ≤ 0.05 and **p ≤ 0.01)

Multiple Regression Fit for 9cpd Stimuli
Integrated Foveal MPOD and
Kurtosis as Predictors

F

Significance

o

5.174*

0.012

o

3.610*

0.039

o

3.397*

0.047

o

0.414

0.665

RGD_0
RGD_2
RGD_4
RGD_6

Table 69
Multiple regression fit significance table for foveal MPOD integrated across 1o assuming stimulus point at highest retinal
o

o

o

o

sensitivity and kurtosis values as predictors for relative glare disability at 0 , 2 , 4 and 6 using 9cpd grating targets. (*p ≤
0.05 and **p ≤ 0.01)

As the independent sample t-test revealed significant differences between RGD
at 0o, 2o and 4o of eccentricity, scatterplot results demonstrated the greatest
amount of variance explained at the 0o (r2 = 0.255) followed by the 2o eccentricity
(r2 = 0.177) then 4o eccentricity (r2 = 0.139) and the least amount of variance
explained at the 6o eccentricity (r2 = 0.026).
Below shows a radial summary plot of correlation values between MPOD
calculated as a discrete value with GD and RGD (Figure 32). The plots show the
differences in correlation results among meridians as well as decreasing
correlation between MPOD and glare attenuation with increasing eccentricity. A
similar radial summary plot of correlation values between MPOD calculated as a
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1o integrated area assuming stimulus point at highest retinal sensitivity with GD
and RGD. Similar differences in correlation results among meridians as well as
decreasing correlation between MPOD and glare attenuation with increasing
eccentricity are seen (Figure 33).

-0.051

-0.081

-0.338

-0.352*

-0.415*

-0.340*
-0.331

-0.172

-0.307

-0.407*

-0.217

-0.101

-0.335

-0.395*
-0.158

-0.323

-0.398*

-0.245

-0.127

-0.491*

-0.319*

-0.405*

-0.342

0.362*

-0.158

-0.143

Figure 32
Summary plots indicating correlation and significance values for corresponding locations of MPOD measured as a
discrete value and both GD (left) and RGD (right) using 9cpd stimuli . (*p ≤ 0.05 and **p ≤ 0.01)

-0.066

-0.099

-0.351*

-0.340

-0.391*

-0.347*
-0.341

-0.201

-0.318

-0.415*

-0.286

-0.114

-0.337

-0.413*

-0.399* -0.127

-0.505*
-0.201

-0.352* -0.401*

-0.399*

-0.421*

-0.321

-0.302

-0.180

-0.193

Figure 33
Summary plots indicating correlation and significance values for corresponding locations of MPOD as a 1o integrated area
assuming stimulus point at highest retinal sensitivity and GD (left) and RGD (right) using 9cpd stimuli. (*p ≤ 0.05 and **p ≤
0.01)
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Intraocular Scatter Correlations with MPOD
Intraocular scatter was evaluated as four separate correlation coefficients: 1)
foveal MPOD discrete value, 2) foveal MPOD integrated across 1o, 3) AUC
integrated across 16o assuming stimulus center and 4) AUC integrated across 16o
assuming stimulus point of highest sensitivity

Intraocular scatter correlations with foveal MPOD discrete value (r = -0.348, p =
0.078), foveal MPOD integrated across 1o (r = -0.346, p = 0.080), AUC integrated
across 16o assuming stimulus center (r = -0.261, p = 0.142) and AUC integrated
across 16o assuming stimulus point of highest sensitivity (r = -0.253, p = 0.156)
were non-significant (Table 70).

Intraocular
Scatter

Foveal
MPOD
Discrete
Point

Foveal
MPOD
Integrated
Stimulus
Highest
Sensitivity

Integrated
AUC MPOD
o
across 16
Stimulus
Center

Integrated
AUC MPOD
o
across 16
Stimulus
Highest
Sensitivity

Pearson
Correlation

-0.348

-0.346

-0.261

-0.253

Sig. (2-tailed)

0.078

0.080

0.142

0.156

Table 70
o

o

Correlation coefficients for intraocular scatter thresholds and MPOD measured at 0 integrated across the 1 stimulus and
o

integrated across the 16 macula.

An independent sample t-test analysis of intraocular scatter differences between
the highest and lowest quartiles of foveal MPOD revealed significant differences
(Table 71).
Independent Samples t-test
Intraocular Scatter

t-value

Sig.

-2.715*

0.015

Table 71
Independent samples t-test for intraocular scatter between the highest and lowest foveal MPOD quartiles. Levene’s Test
for Equal Variances was non-significant so equal variances were assumed. (* p ≤ 0.05 and **p ≤ 0.01)
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A scatterplot of foveal MPOD integrated across 1o with intraocular scatter values
was performed resulting in a r2 = 0.117. An inverse relationship was seen
supporting the hypothesis that higher foveal MPOD levels are associated with
decreased levels of intraocular scatter (Figure 34). Significance for the scatterplot
was calculated for foveal MPOD as a 1o integrated area assuming a stimulus
point at highest retinal sensitivity and intraocular scatter. A non- significant F
value was found between foveal MPOD and intraocular scatter (Table 72).

Figure 34
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1o stimuli versus intraocular scatter.

Regression Fit for Intraocular Scatter
Integrated Foveal MPOD

F

Significance

Intraocular Scatter

3.179

0.084

Table 72
Regression fit significance table for foveal MPOD integrated across 10 and intraocular scatter values

Three summary tables of correlations between foveal MPOD measured as a
discrete point (Table 73), foveal MPOD measured as a 1o integrated area
assuming stimulus center measure (Table 74) and foveal MPOD measured as a
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1o integrated area assuming a stimulus point at highest retinal sensitivity (Table
75) with CS, GD and RGD at all measured retinal eccentricities (0o, 2o, 4o and 6o)
at all measured spatial frequencies (3, 6, 9cpd) are provided below.

Foveal MPOD Measured as a Discrete Point
Contrast Sensitivity

Glare Disability

Relative Glare Disability

3cpd

6cpd

9cpd

3cpd

6cpd

9cpd

3cpd

6cpd

9cpd

0

o

NS

NS

NS

NS

NS

-0.392*

NS

-0.401*

-0.491**

2

o

NS

NS

NS

NS

NS

-0.358*

NS

-0.316*

-0.469**

4o

NS

NS

NS

NS

NS

NS

NS

NS

-0.372**

6o

NS

NS

NS

NS

NS

NS

NS

NS

NS

Table 73
Correlation coefficients for foveal MPOD as a discrete point measure and contrast sensitivity, glare disability and relative
o

o

o

o

glare disability at 0 , 2 , 4 and 6 of eccentricity for 3, 6 and 9cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01)

Foveal MPOD as 1o Integrated Area Assuming Stimulus Center
Contrast Sensitivity

Glare Disability

Relative Glare Disability

3cpd

6cpd

9cpd

3cpd

6cpd

9cpd

3cpd

6cpd

9cpd

o

NS

NS

NS

NS

NS

-0.406*

NS

-0.412*

-0.501**

2o

NS

NS

NS

NS

NS

-0.359*

NS

-0.316*

-0.475**

4

o

NS

NS

NS

NS

NS

NS

NS

NS

-0.368**

6

o

NS

NS

NS

NS

NS

NS

NS

NS

NS

0

Table 74
Correlation coefficients for foveal MPOD measured as a 1o integrated area assuming stimulus center measure and
o

o

o

o

contrast sensitivity, glare disability and relative glare disability at 0 , 2 , 4 and 6 of eccentricity for 3, 6 and 9cpd grating
targets. (* p ≤ 0.05 and **p ≤ 0.01)

Foveal MPOD as 1oIntegrated Area Assuming Stimulus Point of Highest Retinal Sensitivity
Contrast Sensitivity

Glare Disability

Relative Glare Disability

3cpd

6cpd

9cpd

3cpd

6cpd

9cpd

3cpd

6cpd

9cpd

0

o

NS

NS

NS

NS

NS

-0.413*

NS

-0.418*

-0.505**

2

o

NS

NS

NS

NS

NS

-0.377*

NS

-0.315*

-0.489**

4

o

NS

NS

NS

NS

NS

NS

NS

NS

-0.373**

6o

NS

NS

NS

NS

NS

NS

NS

NS

NS

Table 75
Correlation coefficients for foveal MPOD measured as a 1o integrated area assuming a stimulus point at highest retinal
o

o

o

o

sensitivity and contrast sensitivity, glare disability and relative glare disability at 0 , 2 , 4 and 6 of eccentricity for 3, 6 and
9cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01)
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VII. Discussion
A. Macular Pigment Spatial Distribution
The spatial distribution of MP in this sample as measured by cHFP was welldescribed by a first-order exponential function originating at the foveal center in
agreement with ex vivo HPLC studies (Handelman et al., 1988) and a Lorentzian
function across the macula (Stringham et al., 2003 and Wenzel et al., 2006).
Spatial distribution results from this experiment show similar covariance values
when MPOD measures at eccentricities across the macula assuming stimulus
point at highest retinal sensitivity (r2 = 0.907) versus stimulus center (r2 = 0.885)
are fit to a Lorentzian function. The similar covariance values support an
adequate description of MPOD spatial distribution by assuming either stimulus
center measurement or stimulus point at highest retinal sensitivity. Although the
study sample distribution is best fit by a Lorentzian function across the macula,
large individual differences in distribution shape are seen.

The study sample demonstrates a mean positive kurtosis (i.e. leptokurtic) value.
This offers support of the Lorentzian fit to MPOD spatial distribution over a
Gaussian fit due to the higher central peak of the Lorentzian function. The
relatively large variance in the kurtosis values also supports the large variability
in individual MPOD spatial distributions when fit to a Lorentzian function. The
close agreement between the separate AUC measurements suggest that when
considering the spatial distribution across the 16o macula, stimulus center and
stimulus point at highest retinal sensitivity are comparable descriptors. Methods
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of MPOD spatial distribution including kurtotic descriptions and integrated AUC
calculations show substantial variability among individuals and within the
substantial variability is where differences in visual performance measures may
lie.

In an effort to minimize receptive field interaction or underlying photoreceptor
response differences, the MPOD spatial distribution was also fit to a 1 st order
exponential curve excluding the 0o measurement value. The relative agreement
of the y-intercept of the highest retinal sensitivity when the 0o measurement is
excluded (y-intercept = 0.477) versus stimulus center when 0o measurement is
excluded (y-intercept = 0.629) with both the stimulus point of highest retinal
sensitivity with 0o measurement (y-intercept = 0.387) and stimulus center with 0o
measurement (y-intercept = 0.426) may offer support that the point of highest
retinal sensitivity subtended by the stimuli is the measurement point of MPOD
using HFP techniques.

The overall distribution measure of MPOD shows an inverse association with
retinal eccentricity. The trend of decreasing MPOD as a function of eccentricity
has been documented by both ex vivo studies (Snodderly et al., 1984 and Bone
et al., 1985) and in vivo studies (Hammond et al., 1997 and Wooten et al., 2005)
of the MP spatial distribution. The results of this experiment support and confirm
the previously identified first order exponential decay curve exhibited by MP as a
function of retinal eccentricity. Several studies have described a secondary peak
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or ring-like structure of MPOD that is found between approximately 0.50 0 and
0.850 eccentric to fovea in 10-20% of the general population (Berendschot et al.,
2006 and Dietzel et al., 2011). The cHFP device designed and built for this
project focused on the overall spatial distribution from 0o to 8o eccentricity
measured with a 1o stimulus at 2o intervals. Due to this device design,
measurement and verification of predicted ring-like MPOD findings is not within
the scope of the current project but design modifications to the existing cHFP
device would allow such a measurement.

Anatomic structure has also been demonstrated to influence MPOD spatial
profiles. Specifically, Nolan et al. (2008) found that foveal width was associated
with non-typical MP spatial distribution. Increased foveal width was significantly
related to MP spatial profiles due in part to increased length of the foveal cone
axons. The slope of the foveal depression was also shown to influence the slope
of the MPOD spatial distribution: Steep foveal depressions were significantly
related to steep MPOD spatial distributions.

Risk factors such as age and increased oxidative stress along with differences in
foveal anatomic architecture have been shown to create non-exponential
declines in MPOD spatial distribution with increasing eccentricity. Assessment of
MPOD spatial distribution for these individuals would likely be better expressed
as an integrated area under the curve. Results from the current experiment
across 33 subjects ages 22-34 supported a monotonic exponential decay curve
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consistent with Kirby et al. (2010) which found that younger subjects tended to
exhibit a typical exponential decay function with increasing eccentricity when
measured by HFP. Kirby et al. also hypothesized that changes in the typical
exponential function of MPOD distribution with age may be in part to cumulative
SW absorption.

B. Contrast Sensitivity and Glare Disability Across the Macula
The overall distribution measures of CS and GD show an inverse association
with retinal eccentricity. The decreasing CS with increasing retinal eccentricity
demonstrated in this experiment is also supported in previous studies (Pointer et
al., 1989). The inverse association of CS and retinal eccentricity is a
consequence of the simultaneous decreasing cone density and increasing
receptive field size that occurs with increasing retinal eccentricity (Virsu and
Rovamo, 1979). The measure of GD was defined as a difference in CS under no
glare and glare conditions. The subjects’ underlying CS affects both measures
and absolute GD reflected greater variability in sensitivity measures than relative
GD. In order to parse out existing differences in GD specific to glare effects
among individuals, a normalization of the absolute GD measure was determined
through calculation of the RGD defined as (CSNo Glare – CSGlare) / CSNo Glare.

Theoretically, as the MPOD decreases with increasing retinal eccentricity, the
resulting GD should increase and sensitivity measures will decrease. GD was
measured as a difference in CS and followed similar inverse associations with
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retinal eccentricity. When GD was calculated, large variability at each retinal
eccentricity within the sample was seen. The transformation of absolute GD into
RGD allowed differences in sensitivity specific to glare to be identified and
created less variability within the measures at each eccentricity. A greater
number of RGD than GD results followed an expected trend of decreasing
sensitivity with decreasing retinal eccentricity.

Stimuli were not scaled to account for receptive field changes with increasing
sensitivity in order to compare equivalent integrated MPOD measures with
grating targets areas. Increased parafoveal target sizes would require increased
HFP stimuli to allow for equivalent integration comparisons. Due to the
Lorentzian spatial distribution of MPOD across the macula, larger areas of
integration would likely mask small differences between individual MPOD
distributions.

Vertical grating orientations were utilized for CS and GD stimuli to allow for direct
comparisons of results to the existing studies that also used vertical grating
orientations (Loughman et al., 2010 and Nolan et al., 2011). The experimental
design of this project utilized the same vertical grating targets for both glare and
no glare conditions. Identical stimuli for both conditions allowed target resolution
threshold by each subject to be identified in the same manner for both conditions
helping to control for edge detection resulting from microsaccadic activity during
fixation.
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C. Relationship between MPOD, Contrast Sensitivity, Glare Disability and
Intraocular Scatter
Hypothesis #1
MPOD has an inverse relationship with glare disability and contrast sensitivity at
both foveal and parafoveal retinal loci.

Results from this study did not identify an association between MPOD and CS at
foveal or parafoveal loci. Due the non-significant relationship between MPOD
and CS and the calculation of GD as CSNo Glare - CSGlare, no significant
correlations between MPOD and GD were found. However, when underlying CS
results were controlled for by calculating RGD as (CSNo Glare - CSGlare) / CSNo Glare,
study results supported a significant inverse relationship between foveal MPOD
and RGD out to 4o eccentricity using 9cpd targets.

Hypothesis #2
Integrated measures of MPOD across the diameter of the stimulus will better
predict visual performance compared to discrete point measurements.

MPOD was calculated as an integrated measure across the 1 o stimulus
assuming a central stimulus measure and across the 1o stimulus assuming a
point of highest retinal sensitivity. Results from this study demonstrated similar
significant correlations when MPOD measurements assumed either an integrated
measure or a discrete measure. These similarities may be due to relatively small
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differences in corresponding integrated and discrete MPOD measures within an
individual subject. It is likely that both HFP and the adaptive staircase method of
limits CS task involved the stimulus point which subtended the highest retinal
sensitivity.

Hypothesis #3
Integrated MPOD is inversely related to intraocular scatter.

Intraocular scatter was assessed using a psychophysical central flicker
comparison technique. Similar to the HFP device, the perception of subtle flicker
differences were likely identified by the point of highest retinal sensitivity. The
corresponding regions of subtle flicker comparison difference measurement and
MPOD measurement may explain the higher correlation values between foveal
MPOD and intraocular scatter rather than integrated MPOD across the 16 o
macula. Although correlations between foveal MPOD and intraocular scatter
were non-significant, an inverse trend between was demonstrated.

Overall, results of this study demonstrated non-significant correlations between
MPOD and CS at all retinal eccentricities at 3, 6 and 9cpd spatial frequencies.
Only 1 previous non-supplementation study of MP has reported significant
findings between MPOD and CS (Loughman et al., 2010). These differences in
results may be due to differences in experimental design including stimuli
configuration and psychophysical methods. The Loughman et al. (2010) study
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utilized vertical Gabor patches with a spatial Gaussian envelope generated by a
Metropsis Visual Stimulus Generation device (Cambridge Research Systems
Ltd., Cambridge, UK) presented on a 19” CRT monitor which subtended 4.20 of
visual angle. A four alternative forced choice test was used and targets were
randomly presented at a 20 spatial offset from a central fixation cross. An
adaptive staircase method was used to determine contrast threshold. The target
visibility was started above expected subject threshold values (determined from
previous pilot study) and decreased at 0.3 log unit steps until the first reversal
then was presented at 0.15 log unit steps until 12 reversal were recorded.
Threshold was identified at the midpoint of 12 reversal points for five different
spatial frequencies: 1.0, 4.1, 7.5, 11.8 and 20.7cpd.

The hypothesized role of MP influences on CS has been attributed to SW
attenuation effects of chromatic aberration and intraocular scatter leading to
retinal image resolution increases through reduced lateral inhibition and
enhanced receptive field responses (Loughman et al., 2010). Lack of correlation
significance between MPOD and CS may also have been due to the spectral
composition and the predominance of LW light contained within the stimuli and
background. Spectral analysis of the CRT display used in stimuli generation was
performed using the same spectrophotometer (model 650; Photo Research Inc.,
Chatsworth, CA) used in calibration of the LED glare sources.
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Spectrophotometer results for the CRT used showed a luminance output of
20cd/m2 with a peak wavelength of 624nm. The well-documented SW
attenuation property of MP underlies the Optical Hypothesis described earlier.
The absorption bandwidth of MP extends from approximately 400nm to 520nm
with a peak absorbance of 460nm. The peak spectral output of the stimuli and
background of produced by the CRT display used in the experiment is far outside
the absorption spectrum of MP providing a possible explanation for the nonsignificant relationship between MPOD and CS.

3cpd Stimuli GD and RGD
Non-significant correlations of GD at 3cpd with both foveal and eccentric MPOD
measures are likely due to the influence of the underlying CS variability among
subjects. The method used to calculate GD was a difference in CS under no
glare and glare conditions. CS at the fovea and across the macula showed high
variability within the study sample and no significant relationship with MPOD
measures. The lack of significant correlation between foveal and eccentric
MPOD measures with CS likely influences the same lack of correlation between
foveal and eccentric MPOD measures with GD. A function of calculating relative
GD is a normalization of GD and an isolation of glare-dependent effects on CS
measures. Non-significant correlations of RGD at 3cpd with both foveal and
eccentric MPOD measures may be a result of the low spatial frequency stimuli
used. Roumes et al. (2001) and Aguirre et al. (2007) found that the effect of glare
is greatest within spatial frequencies with the highest CS and visual effects due
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to glare conditions decreased CS primarily within the low spatial frequency
range.

Although correlations were non-significant, a significant difference in RGD
between the highest and lowest quartiles of foveal MPOD was identified at 2o
and 4o. Theses significant differences between quartiles exist at low foveal
eccentricities where MPOD is relatively higher than 6o. Additionally, the
calculated effect sizes at 2o and 4o eccentricity were r = 0.484 and r = 0.508,
respectively. Using Cohen’s guidelines (Howell, 2007), correlational effect sizes
greater than 0.4 are generally accepted as large providing that differences
between the highest and lowest foveal MPOD quartiles are statistically significant
and meaningful.

No significant difference in RGD was found at 6o where MPOD is relatively lower.
This dependence on foveal eccentricity and relative MPOD may support a
minimum value of MPOD may be necessary to confer RGD benefits to a subject.
The lack of a significant difference in RGD at 00 eccentricity between the highest
and lowest MPOD quartiles was unexpected. The non-significant difference may
be a result of the high degree of variability within the RGD calculations at 00
among the subject sample for 3cpd stimuli compared to 6cpd and 9cpd stimuli.
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6cpd Stimuli GD and RGD
Non-significant correlations between GD and foveal measures at 6cpd were
identified. These non-significant correlations are likely a result of the underlying
non-significant CS correlations with foveal MPOD or a lesser effect of MPOD
glare attenuation on low to moderate spatial frequencies. Significant correlations
of RGD with foveal MPOD measures were found at 00 and 20 and marginal
significance of RGD with foveal MPOD measures at 40 foveal eccentricity. The
findings of correlational significance with 6cpd stimuli and non-significance with
3cpd stimuli support a possible spatial frequency influence on RGD effects.

Significant differences in RGD between the highest and lowest quartiles of foveal
MPOD were identified at 0o, 2o and 4o of foveal eccentricity with non-significant
differences in GD at the same foveal eccentricities. These differences between
GD and RGD support the importance of normalizing the effects of CS in order to
evaluate distinct glare attenuation effects. Additionally, the calculated effect sizes
for RGD at 0o, 2o and 4o eccentricity were r = 0.468, r = 0.521 and r = 0.475,
respectively. The combination of statistical significance with a robust effect size
suggests that differences between the highest and lowest foveal MPOD quartiles
are meaningful.

The overall range of RGD for 6cpd stimuli at all eccentricities revealed a trend of
increasing RGD with decreasing MPOD. Significant differences in RGD found at
low foveal eccentricities with relatively greater MPOD in combination with non-
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significant differences in RGD at high foveal eccentricities with relatively lower
MPOD further supports a possible minimum value of MPOD necessary to confer
RGD benefits.

9cpd Stimuli GD and RGD
Significant correlations of GD and RGD with foveal MPOD measures at 9cpd
may indicate the influence of MPOD glare attenuation on moderate to high
spatial frequencies. Significant correlations of GD with foveal MPOD is
demonstrated at 0o and 2o foveal eccentricity while significant correlations of
RGD with foveal MPOD are shown at 0o, 2o and 4o of foveal eccentricity.
Significant correlations are also seen between GD and RGD with parafoveal
MPOD measures at 2o and 4o not seen using the 3cpd and 6cpd stimuli. The
overall range of RGD for 9cpd stimuli at all eccentricities revealed a trend of
increasing RGD with decreasing MPOD. The trend of increasing RGD with
decreasing MPOD is exhibited at 6cpd stimuli and 9cpd stimuli but not 3cpd
stimuli, may also support a spatial frequency dependence of MPOD on glare
attenuation. Additionally, the emergence of a significant relationship between
corresponding parafoveal MPOD with both GD and RGD out to 4 o eccentricity
using 9cpd targets suggests a spatial frequency dependence on the glare
attenuation afforded by MP.

The analysis of RGD between the highest and lowest quartiles of foveal MPOD
shows the largest statistically significant effects. The combination of statistical
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significance with a robust effect provides further support of a possible spatial
frequency influence on the glare attenuation effects of MPOD.

The large variability of CS and overlapping 95% confidence intervals within the
study sample at retinal eccentricities of 4o and 6o may explain the significance of
RGD and MPOD and the non-significance of GD and MPOD. The GD value is an
absolute difference between CS under glare conditions and CS with no glare
conditions. This value will be greatly influenced by the underlying CS of the
subject at a given retinal eccentricity. The RGD value is a relative difference
between CS under glare conditions and CS with no glare conditions. Specifically,
RGD is calculated as: RGD = ( CSNo Glare - CSGlare) / (CSGlare) and may better
identify the glare attenuation effects separate from the underlying CS at a given
retinal eccentricity.

Within our study sample, relatively similar significant correlation coefficients were
found between both integrated and discrete measures of MPOD and RGD.
These findings support the shared association between integrated and discrete
MPOD measurements in regards to glare attenuation across the macula. Overall,
foveal MPOD showed the most consistent associations with all 3 spatial
frequency stimuli than parafoveal measures of MPOD. Only at the 9cpd stimuli
did RGD show significant correlations with corresponding MPOD loci. Results
from the data show a similar number of significant coefficients when either
integrated MPOD or discrete is correlated with RGD.
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At all three spatial frequencies, a multiple regression using integrated foveal
MPOD and corresponding kurtosis values as predictors of resulting RGD for
each subject was performed. In all cases, adding kurtosis as an additional
predictor did not increase the variance explained within the regression model.

Intraocular Scatter
Intraocular correlations with foveal and AUC integrated MPOD measurements
were non-significant. However, quartile analysis of the highest and lowest foveal
MPOD found significant differences in intraocular scatter values. The intraocular
scatter assessment required fixation of a central target and direct comparison of
a flickering hemifield. The spectral composition of the glare annulus contained a
large SW light component with a peak wavelength of 460nm closely matching the
spectral absorption characteristics of MP. It is likely that peak MPOD is a greater
contributor to SW light attenuation in regards to intraocular scatter than AUC
integration MPOD values.

Future Directions
A potential follow-up study to the results of this project would be to evaluate the
impact of scaled stimuli on relationship between glare disability and MPOD. The
current results demonstrate decreasing correlation coefficients with increasing
retinal eccentricity using 9cpd stimuli. It would be interesting to learn whether that
decreased significance is a result of lower MPOD creating less glare attenuation
and if the corresponding glare attenuation has a spatial frequency dependence.
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The lack of significant correlations between MPOD and CS could also be
explored further by utilizing chromatic stimuli rather than the achromatic stimuli
reported here. The SW absorption properties of MP are well-documented and
described in detail above. An evaluation of CS using a grating pattern generated
on a SW-dominant background would theoretically be influenced by MPOD.

A number of studies have explored the relationship between CS and
supplementation MP with mixed results. A few of the studies have identified a
significant improvement in CS following supplementation (Richer et al., 1999 and
Richer et al., 2004 and Olmedilla et al., 2003 and Kvansakul et al., 2006) and a
few of the studies have failed to identify a significant association (Bartlett and
Eperjesi, 2007 and Bartlett and Eperjest, 2008 and Nolan et al., 2011). It may be
possible that differences in the findings may be a result of metabolic
bioavailability of the L and Z from the supplement or possible differences in
retinal transport and bindings among participants. In the absence of a SW
component, any improvements in CS due to MP have a likely etiology in the
Neural Hypothesis.

Future directions stemming directly from this project include the isolation of a
neural component to the CS at different retinal loci at different spatial frequency.
A current model of neural blur () incorporates 2 components, equivalent intrinsic
blur (int) assessed as visual acuity and optical blur (opt) assessed as higher
order aberrations. The model suggests the two components, intrinsic blur and
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optical blur, are related to neural blur in the following equation:  = 1 – (opt / int).
The resulting neural blur is the limiting component in visual function. An intriguing
question lies in the role of MP on the resulting neural blur both from the baseline
characteristics to results following supplementation.

Intraocular scatter is highly influenced by inhomogeneities within the ocular
media, lenticular transmission being the primary source. The finding of
correlation non-significance between foveal MPOD and intraocular scatter values
is not surprising given the potential range of ocular transmission values. A
potential supplementation study of the influences of L only, L+Z and L+Z+MZ oral
formulations on resulting MPOD spatial distribution correlated with repeated
intraocular scatter values at 3, 6 and 12 months in younger subjects without
evidence of lenticular changes. This subject sample would likely exhibit the
highest ocular media transmission and may help to identify any improvement in
intraocular scatter correlated to MPOD, if any is to be found.

MPOD has been well-established in the literature in regard to the 3 components
of the Optical Hypothesis when evaluated centrally. Due to the variable nature of
MPOD spatial distribution within the population as a whole, the parafoveal
relationship requires further detailed investigation. Integrated MPOD
measurements demonstrated a significant relationship to relative glare disability
and showed an increased association with higher spatial frequencies. This may
influence how MPOD is currently assessed clinically and how supplementation

P a g e | 149

studies evaluating visual performance related to MPOD are performed. Foveal
MPOD measurements remained the strongest predictor of disability glare from 00
to 40 of retinal eccentricity and, although non-significant, showed an inverse
relationship with measured intraocular scatter values. The spatial distribution
profile likely remains a critical part of both the Neural and Protection Hypotheses.
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Appendix 1

Figure 13
Mean contrast sensitivity values 3cpd stimuli along the horizontal meridian for the 33 subject sample as a function of
foveal eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast
sensitivity with flanking glare. Error bars indicate a 95% confidence interval.
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Figure 14
Mean contrast sensitivity values 3cpd stimuli along the vertical meridian for the 33 subject sample as a function of foveal
eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast
sensitivity with flanking glare. Error bars indicate a 95% confidence interval.
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Figure 15
Mean contrast sensitivity values 6cpd stimuli along the horizontal meridian for the 33 subject sample as a function of
foveal eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast
sensitivity with flanking glare. Error bars indicate a 95% confidence interval.
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Figure 16
Mean contrast sensitivity values 6cpd stimuli along the vertical meridian for the 33 subject sample
as a function of foveal eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare and red squares
represent contrast sensitivity with flanking glare. Error bars indicate a 95% confidence interval.
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Figure 17
Mean contrast sensitivity values 9cpd stimuli along the horizontal meridian for the 33 subject sample as a function of
foveal eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast
sensitivity with flanking glare. Error bars indicate a 95% confidence interval.

P a g e | 172

Figure 18
Mean contrast sensitivity values 9cpd stimuli along the vertical meridian for the 33 subject sample
as a function of foveal eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare and red squares
represent contrast sensitivity with flanking glare. Error bars indicate a 95% confidence interval.
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Figure 19
Mean contrast sensitivity values for all targets (3,6,9cpd) along all meridians (horizontal and vertical) for the 33 subject
sample as a function of foveal eccentricity. Blue diamonds indicate contrast sensitivity without flanking glare for 3cpd
stimuli, red squares indicate contrast sensitivity with flanking glare for 3cpd stimuli , green triangles indicate contrast
sensitivity without flanking glare for 6cpd stimuli, lavender X indicates contrast sensitivity with flanking glare for 6cpd
stimuli, blue X indicates contrast sensitivity without flanking glare for 9cpd stimuli and orange circles indicate contrast
sensitivity with flanking glare for 9cpd stimuli.
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Appendix 2
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1.000

0.962

0.964

0.957

Sig. (2-tailed)

-------

p<0.001

p<0.001

p<0.001

Pearson Correlation

0.962

1.000

0.955

0.965

Sig. (2-tailed)

p<0.001

-------

p<0.001

p<0.001

Pearson Correlation

0.964

0.955

1.000

0.968

Sig. (2-tailed)

p<0.001

p<0.001

-------

p<0.001

Pearson Correlation

0.957

0.965

0.968

1.000

Sig. (2-tailed)

p<0.001

p<0.001

p<0.001

-------

Table 1
Table indicating correlation and significance measures for MPOD at 2o of eccentricity along the 4 principle meridians

Temporal
Superior
Nasal
Inferior

Temporal

Superior

Nasal

Inferior

Pearson Correlation

1.000

0.931

0.942

0.930

Sig. (2-tailed)

-------

p<0.001

p<0.001

p<0.001

Pearson Correlation

0.931

1.000

0.938

0.947

Sig. (2-tailed)

p<0.001

-------

p<0.001

p<0.001

Pearson Correlation

0.942

0.938

1.000

0.928

Sig. (2-tailed)

p<0.001

p<0.001

-------

p<0.001

Pearson Correlation

0.930

0.947

0.928

1.000

Sig. (2-tailed)

p<0.001

p<0.001

p<0.001

-------

Table 2
Table indicating correlation and significance measures for MPOD at 4o of eccentricity along the 4 principle meridians

Temporal
Superior
Nasal
Inferior

Temporal

Superior

Nasal

Inferior

Pearson Correlation

1.000

0.894

0.915

0.929

Sig. (2-tailed)

-------

p<0.001

p<0.001

p<0.001

Pearson Correlation

0.894

1.000

0.875

0.893

Sig. (2-tailed)

p<0.001

-------

p<0.001

p<0.001

Pearson Correlation

0.925

0.875

1.000

0.911

Sig. (2-tailed)

p<0.001

p<0.001

-------

p<0.001

Pearson Correlation

0.929

0.893

0.911

1.000

Sig. (2-tailed)

p<0.001

p<0.001

p<0.001

-------

Table 3
Table indicating correlation and significance measures for MPOD at 6o of eccentricity along the 4 principle meridians

P a g e | 175

Kurtosis Value
Subject 1
Subject 2
Subject 3
Subject 4
Subject 5
Subject 6
Subject 7
Subject 8
Subject 9
Subject 10
Subject 11
Subject 12
Subject 13
Subject 14
Subject 15
Subject 16
Subject 17
Subject 18
Subject 19
Subject 20
Subject 21
Subject 22
Subject 23
Subject 24
Subject 25
Subject 26
Subject 27
Subject 28
Subject 29
Subject 30
Subject 31
Subject 32
Subject 33
Mean
Std Dev

5.166
2.554
4.577
4.308
3.042
2.175
3.363
1.704
1.837
2.271
5.313
5.215
0.399
4.312
2.731
5.395
0.806
3.302
2.392
7.154
-0.763
1.627
4.603
1.937
2.112
2.246
0.825
1.222
3.719
2.591
1.049
3.102
-0.503
2.781
1.809

Integrated
AUC Stimuli
Center
1.762
1.879
2.133
1.765
2.098
1.912
2.448
1.954
1.988
1.781
1.551
1.881
1.831
1.498
2.571
1.633
2.018
1.505
1.638
1.513
1.705
2.371
1.666
1.579
2.135
0.851
1.245
1.087
1.346
2.587
1.693
1.566
1.487
1.778
0.393

Integrated AUC
Stimuli Highest
Sensitivity Point
1.467
1.577
1.772
1.457
1.734
1.598
2.051
1.649
1.671
1.501
1.279
1.534
1.581
1.251
2.142
1.358
1.722
1.255
1.375
1.223
1.524
2.003
1.392
1.313
1.789
0.703
1.051
0.913
1.109
2.154
1.436
1.296
1.258
1.489
0.331

Table 4
Calculated values for kurtosis, integrated AUC assuming stimulus center and integrated AUC assuming stimulus point of
highest retinal sensitivity for the 33 subject sample using MPOD values measured at 0 o, 2o, 4o, 6o and 8o eccentricity.
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CS_0

3cpd
Foveal MPOD
Pearson Correlation
Discrete Point
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Center
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Highest Sensitivity
Sig. (2-tailed)
Table 8

o

o

o

o

Horiz_CS_2 Horiz_CS_4 Horiz_CS_6

0.087

0.054

0.285

0.154

0.629

0.765

0.108

0.391

0.081

0.054

0.285

0.162

0.652

0.765

0.108

0.369

0.076

0.052

0.283

0.163

0.675

0.775

0.110

0.364

o

o

o

0

o

Correlation coefficients for MPOD at 0 and horizontal meridian contrast sensitivity at 0 , 2 , 4 and 6 for 3cpd grating
targets.

CS_0

3cpd
Peak Foveal MPOD
Pearson Correlation
Discrete Point
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Center
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Highest Sensitivity
Sig. (2-tailed)

o

Vert_CS_2

o

o

Vert_CS_4 Vert_CS_6

0.087

0.013

0.117

0.040

0.629

0.944

0.518

0.823

0.081

0.018

0.127

0.053

0.652

0.919

0.481

0.771

0.076

0.019

0.127

0.057

0.675

0.917

0.482

0.753

Table 9
o

o

o

o

o

Correlation coefficients for MPOD at 0 and vertical meridian contrast sensitivity at 0 , 2 , 4 and 6 for 3cpd grating
targets.

CS_0

3cpd
Foveal MPOD
Pearson Correlation
Discrete Point
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Center
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Highest Sensitivity
Sig. (2-tailed)

o

CS_2

o

CS_4

o

CS_6

0.087

-0.013

0.180

0.076

0.629

0.944

0.316

0.673

0.081

-0.014

0.185

0.088

0.652

0.938

0.303

0.627

0.076

-0.017

0.185

0.092

0.675

0.924

0.304

0.611

Table 10
o

o

o

o

o

o

Correlation coefficients for MPOD at 0 and mean contrast sensitivity at 0 , 2 , 4 and 6 for 3cpd grating targets.

o
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o

Horiz_CS_2

3cpd
o

2 MPOD Discrete
Pearson Correlation
Point

-0.215
0.229

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.222
0.213

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.278
0.117

Sig. (2-tailed)
Table 11
o

o

Correlation coefficients for MPOD at 2 and horizontal meridian contrast sensitivity at 2 for 3cpd grating targets.

o

Vert_CS_2

3cpd
o

2 MPOD Discrete
Pearson Correlation
Point

-0.202
0.260

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.214
0.232

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.276
0.120

Sig. (2-tailed)
Table 12

o

o

Correlation coefficients for MPOD at 2 and vertical meridian contrast sensitivity at 2 for 3cpd grating targets.

CS_2

3cpd

o

o

2 MPOD Discrete
Pearson Correlation
Point

-0.214
0.232

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.285
0.108

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

0.062

Sig. (2-tailed)
Table 13

o

-0.328

o

Correlation coefficients for MPOD at 2 and contrast sensitivity at 2 for 3cpd grating targets.
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o

Horiz_CS_4

3cpd
o

4 MPOD Discrete
Pearson Correlation
Point

-0.099
0.583

Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.120
0.506

Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.105
0.560

Sig. (2-tailed)
Table 14
o

o

Correlation coefficients for MPOD at 4 and horizontal meridian contrast sensitivity at 4 for 3cpd grating targets.

o

Vert_CS_4

3cpd
o

4 MPOD Discrete
Pearson Correlation
Point

-0.197
0.272

Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.228
0.202

Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.245
0.170

Sig. (2-tailed)
Table 15
o

o

Correlation coefficients for MPOD at 4 and vertical meridian contrast sensitivity at 4 for 3cpd grating targets.

CS_4

3cpd

o

o

4 MPOD Discrete
Pearson Correlation
Point

-0.129
0.474

Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.138
0.444

Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

0.463

Sig. (2-tailed)
Table 16

o

-0.132

o

Correlation coefficients for MPOD at 4 and contrast sensitivity at 4 for 3cpd grating targets.
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o

Horiz_CS_6

3cpd
o

6 MPOD Discrete
Pearson Correlation
Point

-0.113
0.531

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.179
0.319

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.057
0.752

Sig. (2-tailed)
Table 17
o

o

Correlation coefficients for MPOD at 6 and horizontal meridian contrast sensitivity at 6 for 3cpd grating targets.

o

Vert_CS_6

3cpd
o

6 MPOD Discrete
Pearson Correlation
Point

-0.191
0.288

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.250
0.160

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.139
0.441

Sig. (2-tailed)
Table 18

o

o

Correlation coefficients for MPOD at 6 and vertical meridian contrast sensitivity at 6 for 3cpd grating targets.

CS_6

3cpd

o

o

6 MPOD Discrete
Pearson Correlation
Point

-0.148
0.412

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.207
0.248

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

0.622

Sig. (2-tailed)
Table 19

o

-0.089

o

Correlation coefficients for MPOD at 6 and contrast sensitivity at 6 for 3cpd grating targets.
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Independent Samples ttest
3cpd

t-value

Sig.

CS_0o

0.299

0.769

CS_2o

0.416

0.683

CS_4o

0.475

0.641

o

0.713

0.486

CS_6
Table 20

o

o

o

o

Independent samples t-test for contrast sensitivity at 0 , 2 , 4 and 6 for 6cpd grating targets between the highest and
lowest quartiles of peak foveal MPOD integrated across 1o assuming stimulus point at highest retinal sensitivity. Levene’s
Test for Equal Variances was non-significant so equal variances were assumed.

6cpd
Foveal MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
Foveal MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
Foveal MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 21

CS_0o

Horiz_CS_2o

Horiz_CS_4o

Horiz_CS_6o

0.237

0.027

0.222

0.202

0.183

0.883

0.214

0.260

0.227

0.031

0.230

0.214

0.204

0.864

0.198

0.231

0.215

0.024

0.230

0.216

0.229

0.894

0.197

0.227

o

o

o

o

o

Correlation coefficients for MPOD at 0 and horizontal meridian contrast sensitivity at 0 , 2 , 4 and 6 for 6cpd grating
targets.

6cpd
Foveal MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
Foveal MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
Foveal MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 22

o

CS_0o

Vert_CS_2o

Vert_CS_4o

Vert_CS_6o

0.237

0.228

0.186

0.240

0.183

0.202

0.301

0.179

0.227

0.236

0.205

0.254

0.204

0.186

0.253

0.154

0.215

0.232

0.214

0.263

0.229

0.194

0.232

0.140

o

o

o

o

Correlation coefficients for MPOD at 0 and horizontal meridian contrast sensitivity at 0 , 2 , 4 and 6 for 6cpd grating
targets.
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6cpd
Foveal MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Center
Sig. (2-tailed)
Foveal MPOD
Integrated Stimulus Pearson Correlation
Highest Sensitivity
Sig. (2-tailed)

CS_00

CS_20

CS_40

CS_60

0.237

0.192

0.213

0.228

0.183

0.285

0.235

0.203

0.227

0.200

0.226

0.238

0.204

0.265

0.206

0.183

0.215

0.193

0.228

0.239

0.229

0.281

0.201

0.180

Table 23
o

o

o

o

o

Correlation coefficients for MPOD at 0 and mean contrast sensitivity at 0 , 2 , 4 and 6 for 6cpd grating targets.

Horiz_CS_2o

6cpd
o

2 MPOD Discrete
Pearson Correlation
Point

-0.234
0.190

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.254
0.154

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.300
0.090

Sig. (2-tailed)
Table 24

o

o

Correlation coefficients for MPOD at 2 and horizontal meridian contrast sensitivity at 2 for 6cpd grating targets.

Vert_CS_2o

6cpd
o

2 MPOD Discrete
Pearson Correlation
Point

-0.134
0.456

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.149
0.408

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.262
0.141

Sig. (2-tailed)
Table 25
o

o

Correlation coefficients for MPOD at 2 and vertical meridian contrast sensitivity at 2 for 6cpd grating targets.
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6cpd

CS_2

o

o

2 MPOD Discrete
Pearson Correlation
Point

-0.074
0.681

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.180
0.317

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.271
0.127

Sig. (2-tailed)
Table 26
o

o

Correlation coefficients for MPOD at 2 and mean contrast sensitivity at 2 for 6cpd grating targets.

o

6cpd

Horiz_CS_4

o

4 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

0.001
0.997

o

4 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)

-0.024
0.895

o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

-0.016
0.932

Table 27
o

o

Correlation coefficients for MPOD at 4 and horizontal meridian contrast sensitivity at 4 for 6cpd grating targets.

o

6cpd

Vert_CS_4

o

4 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

0.023
0.897

o

4 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)

-0.008
0.964

o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

-0.070
0.699

Table 28
o

o

Correlation coefficients for MPOD at 4 and horizontal meridian contrast sensitivity at 4 for 6cpd grating targets.
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CS_4

6cpd

o

o

4 MPOD Discrete
Pearson Correlation
Point

-0.023
0.899

Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.066
0.713

Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.091
0.616

Sig. (2-tailed)
Table 29
o

o

Correlation coefficients for MPOD at 4 and mean contrast sensitivity at 4 for 6cpd grating targets.

o

6cpd

Horiz_CS_6

o

6 MPOD Discrete
Pearson Correlation
Point

0.024
0.896

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.073
0.687

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

0.016
0.931

Sig. (2-tailed)
Table 30
o

o

Correlation coefficients for MPOD at 6 and horizontal meridian contrast sensitivity at 6 for 6cpd grating targets.

o

6cpd

Vert_CS_6

o

6 MPOD Discrete
Pearson Correlation
Point

0.182
0.310

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

0.145
0.421

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

0.205
0.252

Sig. (2-tailed)
Table 31
o

o

Correlation coefficients for MPOD at 6 and vertical meridian contrast sensitivity at 6 for 6cpd grating targets.
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6cpd

CS_6

o

o

6 MPOD Discrete
Pearson Correlation
Point

0.011
0.954

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

0.074
0.684

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

0.131
0.467

Sig. (2-tailed)
Table 32
o

o

Correlation coefficients for MPOD at 6 and contrast sensitivity at 6 for 6cpd grating targets.

Independent Samples ttest
6cpd

t-value

Sig.

CS_0

o

0.995

0.355

CS_2

o

0.947

0.358

CS_4

o

1.130

0.275

CS_6

o

1.137

0.272

Table 33

o

o

o

o

Independent samples t-test for contrast sensitivity at 0 , 2 , 4 and 6 for 6cpd grating targets between the highest and
lowest quartiles of peak foveal MPOD integrated across 1o assuming stimulus point at highest retinal sensitivity. Levene’s
Test for Equal Variances was non-significant so equal variances were assumed.

CS_0

9cpd
Foveal MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
Foveal MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
Foveal MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 34

o

o

o

o

o

Horiz_CS_2

Horiz_CS_4

Horiz_CS_6

0.148

0.099

0.103

0.167

0.412

0.583

0.567

0.354

0.143

0.107

0.114

0.175

0.428

0.554

0.526

0.331

0.133

0.103

0.114

0.175

0.461

0.570

0.526

0.331

o

o

o

o

Correlation coefficients for MPOD at 0 and horizontal meridian contrast sensitivity at 0 , 2 , 4 and 6 for 9cpd grating
targets.
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9cpd

CS_0

Foveal MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
Foveal MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
Foveal MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

o

Vert_CS_2

o

o

o

Vert_CS_4

Vert_CS_6

0.148

-0.188

-0.020

-0.015

0.412

0.294

0.910

0.934

0.143

-0.171

-0.005

-0.006

0.428

0.342

0.978

0.974

0.133

-0.165

-0.001

-0.001

0.461

0.360

0.997

0.998

Table 35
o

o

o

o

o

Correlation coefficients for MPOD at 0 and vertical meridian contrast sensitivity at 0 , 2 , 4 and 6 for 9cpd grating
targets.

9cpd

CS_0

Foveal MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
Foveal MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
Foveal MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

o

CS_2

o

CS_4

o

o

0.148

-0.106

-0.021

0.067

0.412

0.558

0.908

0.713

0.143

-0.089

-0.005

0.075

0.428

0.622

0.979

0.678

0.133

-0.090

-0.004

0.077

0.461

0.620

0.982

0.669

Table 36
o

o

o

o

o

Correlation coefficients for MPOD at 0 and mean contrast sensitivity at 0 , 2 , 4 and 6 for 9cpd grating targets

o

9cpd

Horiz_CS_2

o

2 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

-0.156
0.386

o

2 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)

-0.184
0.306

o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

-0.248
0.165

Table 37
o

CS_6

o

Correlation coefficients for MPOD at 2 and horizontal meridian contrast sensitivity at 2 for 9cpd grating targets.
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o

9cpd

Vert_CS_2

o

2 MPOD Discrete
Pearson Correlation
Point

-0.278
0.117

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.290
0.102

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.340
0.053

Sig. (2-tailed)
Table 38
o

o

Correlation coefficients for MPOD at 2 and vertical meridian contrast sensitivity at 2 for 9cpd grating targets.

9cpd

CS_2

o

o

2 MPOD Discrete
Pearson Correlation
Point

-0.220
0.219

Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.262
0.141

Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.297
0.093

Sig. (2-tailed)
Table 39
o

o

Correlation coefficients for MPOD at 2 and contrast sensitivity at 2 for 9cpd grating targets.

o

9cpd

Horiz_CS_4

o

4 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

-0.163
0.366

o

4 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)

-0.174
0.332

o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

-0.179
0.318

Table 40
o

o

Correlation coefficients for MPOD at 4 and horizontal meridian contrast sensitivity at 4 for 9cpd grating targets.
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o

Vert_CS_4

9cpd
o

4 MPOD Discrete
Pearson Correlation
Point

-0.223
0.213

Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.294
0.096

Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.309
0.081

Sig. (2-tailed)
Table 41
o

o

Correlation coefficients for MPOD at 4 and vertical meridian contrast sensitivity at 4 for 9cpd grating targets.

CS_4

9cpd

o

o

4 MPOD Discrete
Pearson Correlation
Point

-0.271
0.127

Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.292
0.099

Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.301
0.088

Sig. (2-tailed)
Table 42
o

o

Correlation coefficients for MPOD at 4 and mean contrast sensitivity at 4 for 9cpd grating targets.

o

Horiz_CS_6

9cpd
o

6 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

-0.013
0.943

o

6 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)

-0.062
0.730

o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)

-0.022
0.902

Table 43
o

o

Correlation coefficients for MPOD at 6 and horizontal meridian contrast sensitivity at 6 for 9cpd grating targets.
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o

Vert_CS_6

9cpd
o

6 MPOD Discrete
Pearson Correlation
Point

-0.110
0.543

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.128
0.479

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.055
0.763

Sig. (2-tailed)
Table 44
o

o

Correlation coefficients for MPOD at 6 and vertical meridian contrast sensitivity at 6 for 9cpd grating targets.

CS_6

9cpd

o

o

6 MPOD Discrete
Pearson Correlation
Point

-0.109
0.547

Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center

-0.128
0.477

Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity

-0.067
0.710

Sig. (2-tailed)
Table 45
o

o

Correlation coefficients for MPOD at 6 and contrast sensitivity at 6 for 9cpd grating targets.

Independent Samples ttest
9cpd

Table 46

t-value

Sig.

CS_0

0

0.792

0.440

CS_2

0

0.669

0.494

CS_4

0

0.141

0.890

CS_6

0

0.442

0.665

o

o

o

o

Independent samples t-test for contrast sensitivity at 0 , 2 , 4 and, 4 for 6cpd grating targets between the highest and
lowest quartiles of peak foveal MPOD integrated across 10 assuming stimulus point at highest retinal sensitivity. Levene’s
Test for Equal Variances was non-significant so equal variances were assumed.
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o

3cpd
Peak Foveal MPOD Pearson
Discrete Point Correlation
Sig. (2-tailed)
Peak Foveal MPOD
Pearson
Integrated Stimulus
Correlation
Center
Sig. (2-tailed)
Peak Foveal MPOD
Pearson
Integrated Stimulus
Correlation
Highest Sensitivity
Sig. (2-tailed)
Table 47

o

o

GD_0

RGD_0

GD_2

RGD_2

-0.079

-0.205

-0.327

0.663

0.252

-0.101

o

o

o

o

RGD_4

GD_6

RGD_6

-0.335

-0.205

-0.261

-0.219

-0.254

0.063

0.058

0.253

0.143

0.222

0.150

-0.217

-0.333

-0.342

-0.208

-0.266

-0.210

-0.251

0.575

0.226

0.058

0.056

0.245

0.134

0.241

0.155

-0.083

-0.228

-0.331

-0.340

-0.205

-0.264

-0.204

-0.249

0.646

0.203

0.060

0.055

0.253

0.138

0.256

0.159

o

o

o

o

o

Correlation coefficients for MPOD at 0 and glare disability and relative glare disability at 0 , 2 , 4 and 6 for 3cpd grating targets.

o

RGD_2

-0.240

-0.138

0.179

0.445

-0.217

-0.113

0.225

0.530

-0.331

-0.340

0.060

0.053

GD_2

3cpd

o

o

2 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 48

o

o

Correlation coefficients for MPOD at 2 and glare disability and relative glare disability at 2 for 3cpd grating targets.

GD_4

3cpd

o

o

RGD_4

o

4 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

-0.022

0.046

0.904

0.801

0.052

-0.142

0.774

0.432

0.027

0.112

0.880

0.534

o

4 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 49
o

o

GD_4

o

Correlation coefficients for MPOD at 4 and glare disability and relative glare disability at 4 for 3cpd grating targets.
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3cpd

o

RGD_6

-0.176

-0.116

0.326

0.521

-0.243

-0.166

0.173

0.357

-0.224

-0.208

0.210

0.244

GD_6

o

o

6 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 50
o

o

Correlation coefficients for MPOD at 6 and glare disability and relative glare disability at 6 for 3cpd grating targets.

Regression Fit for 3cpd Stimuli
Integrated Foveal MPOD

F

Significance

o

1.368

0.251

o

4.073

0.052

o

2.309

0.139

o

2.567

0.119

RGD_0
RGD_2
RGD_4
RGD_6

Table 53
Regression fit significance table for foveal MPOD integrated across 1o assuming stimulus point at highest retinal
o

o

o

o

sensitivity and relative glare disability at 0 , 2 , 4 and 6 using 3cpd grating targets.

Multiple Regression Fit for 3cpd Stimuli
Integrated Foveal MPOD and
Kurtosis as Predictors

F

Significance

o

0.720

0.495

o

1.992

0.154

o

1.912

0.165

o

1.659

0.207

RGD_0
RGD_2
RGD_4
RGD_6

Table 54
Multiple regression fit significance table for foveal MPOD integrated across 1o assuming stimulus point at highest retinal
o

o

o

o

sensitivity and kurtosis values as predictors for relative glare disability at 0 , 2 , 4 and 6 using 3cpd grating targets.
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6cpd

o

RGD_2

-0.294

-0.299

0.096

0.091

-0.288

-0.298

0.104

0.092

-0.232

-0.267

0.194

0.133

GD_2

o

o

2 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
o

2 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

2 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 56
o

o

Correlation coefficients for MPOD at 2 and glare disability and relative glare disability at 2 for 6cpd grating targets.

6cpd

o

RGD_4

-0.095

-0.149

0.600

0.408

-0.115

-0.138

0.525

0.444

-0.127

-0.151

0.481

0.401

GD_4

o

o

4 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
o

4 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

4 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 57

o

o

Correlation coefficients for MPOD at 4 and glare disability and relative glare disability at 4 for 6cpd grating targets.

6cpd

GD_6

o

o

RGD_6

o

6 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)

0.020

-0.053

0.914

0.770

-0.061

-0.142

0.735

0.431

-0.017

-0.113

0.924

0.530

o

6 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 58
o

o

Correlation coefficients for MPOD at 6 and glare disability and relative glare disability at 6 for 6cpd grating targets.
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Multiple Regression Fit for 6cpd Stimuli
Integrated Foveal MPOD and
Kurtosis as Predictors

F

Significance

o

3.211

0.054

o

2.207

0.128

o

1.140

0.333

o

0.503

0.610

RGD_0
RGD_2
RGD_4
RGD_6

Table 61
Multiple regression fit significance table for foveal MPOD integrated across 1o assuming stimulus point at highest retinal
o

o

o

o

sensitivity and kurtosis values as predictors for relative glare disability at 0 , 2 , 4 and 6 using 6cpd grating targets.

9cpd

o

RGD_6

-0.103

-0.078

0.567

0.667

-0.141

-0.124

0.432

0.493

-0.087

-0.126

0.629

0.485

GD_6

o

o

6 MPOD Discrete
Pearson Correlation
Point
Sig. (2-tailed)
o

6 MPOD Integrated
Pearson Correlation
Stimulus Center
Sig. (2-tailed)
o

6 MPOD Integrated
Stimulus Highest Pearson Correlation
Sensitivity
Sig. (2-tailed)
Table 65
o

o

Correlation coefficients for MPOD at 6 and glare disability and relative glare disability at 6 for 9cpd grating targets.

